aman-dev-codes commited on
Commit ·
1bc0679
0
Parent(s):
ichorbio Biosimilar Reference Database v0.1.3
Browse files- .gitattributes +60 -0
- CHANGELOG.md +21 -0
- CITATION.cff +12 -0
- LICENSE.txt +19 -0
- README.md +49 -0
- antibodies.csv +0 -0
- data_dictionary.csv +44 -0
- dataset.jsonld +95 -0
- ichorbio_bsr.json +0 -0
- llms.txt +22 -0
- measurements.csv +0 -0
- methods.csv +6 -0
- samples.csv +481 -0
- sequences.fasta +0 -0
- summary_wide.csv +481 -0
.gitattributes
ADDED
|
@@ -0,0 +1,60 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
*.7z filter=lfs diff=lfs merge=lfs -text
|
| 2 |
+
*.arrow filter=lfs diff=lfs merge=lfs -text
|
| 3 |
+
*.avro filter=lfs diff=lfs merge=lfs -text
|
| 4 |
+
*.bin filter=lfs diff=lfs merge=lfs -text
|
| 5 |
+
*.bz2 filter=lfs diff=lfs merge=lfs -text
|
| 6 |
+
*.ckpt filter=lfs diff=lfs merge=lfs -text
|
| 7 |
+
*.ftz filter=lfs diff=lfs merge=lfs -text
|
| 8 |
+
*.gz filter=lfs diff=lfs merge=lfs -text
|
| 9 |
+
*.h5 filter=lfs diff=lfs merge=lfs -text
|
| 10 |
+
*.joblib filter=lfs diff=lfs merge=lfs -text
|
| 11 |
+
*.lfs.* filter=lfs diff=lfs merge=lfs -text
|
| 12 |
+
*.lz4 filter=lfs diff=lfs merge=lfs -text
|
| 13 |
+
*.mds filter=lfs diff=lfs merge=lfs -text
|
| 14 |
+
*.mlmodel filter=lfs diff=lfs merge=lfs -text
|
| 15 |
+
*.model filter=lfs diff=lfs merge=lfs -text
|
| 16 |
+
*.msgpack filter=lfs diff=lfs merge=lfs -text
|
| 17 |
+
*.npy filter=lfs diff=lfs merge=lfs -text
|
| 18 |
+
*.npz filter=lfs diff=lfs merge=lfs -text
|
| 19 |
+
*.onnx filter=lfs diff=lfs merge=lfs -text
|
| 20 |
+
*.ot filter=lfs diff=lfs merge=lfs -text
|
| 21 |
+
*.parquet filter=lfs diff=lfs merge=lfs -text
|
| 22 |
+
*.pb filter=lfs diff=lfs merge=lfs -text
|
| 23 |
+
*.pickle filter=lfs diff=lfs merge=lfs -text
|
| 24 |
+
*.pkl filter=lfs diff=lfs merge=lfs -text
|
| 25 |
+
*.pt filter=lfs diff=lfs merge=lfs -text
|
| 26 |
+
*.pth filter=lfs diff=lfs merge=lfs -text
|
| 27 |
+
*.rar filter=lfs diff=lfs merge=lfs -text
|
| 28 |
+
*.safetensors filter=lfs diff=lfs merge=lfs -text
|
| 29 |
+
saved_model/**/* filter=lfs diff=lfs merge=lfs -text
|
| 30 |
+
*.tar.* filter=lfs diff=lfs merge=lfs -text
|
| 31 |
+
*.tar filter=lfs diff=lfs merge=lfs -text
|
| 32 |
+
*.tflite filter=lfs diff=lfs merge=lfs -text
|
| 33 |
+
*.tgz filter=lfs diff=lfs merge=lfs -text
|
| 34 |
+
*.wasm filter=lfs diff=lfs merge=lfs -text
|
| 35 |
+
*.xz filter=lfs diff=lfs merge=lfs -text
|
| 36 |
+
*.zip filter=lfs diff=lfs merge=lfs -text
|
| 37 |
+
*.zst filter=lfs diff=lfs merge=lfs -text
|
| 38 |
+
*tfevents* filter=lfs diff=lfs merge=lfs -text
|
| 39 |
+
# Audio files - uncompressed
|
| 40 |
+
*.pcm filter=lfs diff=lfs merge=lfs -text
|
| 41 |
+
*.sam filter=lfs diff=lfs merge=lfs -text
|
| 42 |
+
*.raw filter=lfs diff=lfs merge=lfs -text
|
| 43 |
+
# Audio files - compressed
|
| 44 |
+
*.aac filter=lfs diff=lfs merge=lfs -text
|
| 45 |
+
*.flac filter=lfs diff=lfs merge=lfs -text
|
| 46 |
+
*.mp3 filter=lfs diff=lfs merge=lfs -text
|
| 47 |
+
*.ogg filter=lfs diff=lfs merge=lfs -text
|
| 48 |
+
*.wav filter=lfs diff=lfs merge=lfs -text
|
| 49 |
+
# Image files - uncompressed
|
| 50 |
+
*.bmp filter=lfs diff=lfs merge=lfs -text
|
| 51 |
+
*.gif filter=lfs diff=lfs merge=lfs -text
|
| 52 |
+
*.png filter=lfs diff=lfs merge=lfs -text
|
| 53 |
+
*.tiff filter=lfs diff=lfs merge=lfs -text
|
| 54 |
+
# Image files - compressed
|
| 55 |
+
*.jpg filter=lfs diff=lfs merge=lfs -text
|
| 56 |
+
*.jpeg filter=lfs diff=lfs merge=lfs -text
|
| 57 |
+
*.webp filter=lfs diff=lfs merge=lfs -text
|
| 58 |
+
# Video files - compressed
|
| 59 |
+
*.mp4 filter=lfs diff=lfs merge=lfs -text
|
| 60 |
+
*.webm filter=lfs diff=lfs merge=lfs -text
|
CHANGELOG.md
ADDED
|
@@ -0,0 +1,21 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Changelog
|
| 2 |
+
|
| 3 |
+
## v0.1.3
|
| 4 |
+
- Expanded SEC-HPLC purity from 4 to **82 biosimilars**, from the full supplier CoA vault
|
| 5 |
+
(coa.ichor.bio), with lot numbers and concentrations.
|
| 6 |
+
- For 68 of them, recorded the **exact monomer %** read from the CoA chromatogram peak table
|
| 7 |
+
(280 nm main peak), replacing the earlier ">95%" placeholder; the other 14 keep the CoA's
|
| 8 |
+
>95%/≥95% specification where no chromatogram is provided.
|
| 9 |
+
|
| 10 |
+
## v0.1.2
|
| 11 |
+
- Added the first SEC-HPLC purity values from supplier Certificates of Analysis for 4 biosimilars
|
| 12 |
+
(Selicrelumab, Farletuzumab, Bococizumab, Romosozumab).
|
| 13 |
+
- Added a SEC-HPLC method (`M-SEC-HPLC`) and filled lot number + concentration on sample rows.
|
| 14 |
+
|
| 15 |
+
## v0.1.1
|
| 16 |
+
- Column and formatting cleanup of the antibodies table.
|
| 17 |
+
- Set `expression_system` to `CHO` for all antibodies.
|
| 18 |
+
|
| 19 |
+
## v0.1.0
|
| 20 |
+
- Seed release: 480 antibodies with sequences + identity; 960 computed values (MW, theoretical pI).
|
| 21 |
+
- Structure established (Antibodies/Samples/Methods/Measurements + data dictionary).
|
CITATION.cff
ADDED
|
@@ -0,0 +1,12 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
cff-version: 1.2.0
|
| 2 |
+
title: "ichorbio Biosimilar Reference Database"
|
| 3 |
+
message: "If you use this dataset, please cite it using the metadata below and tell us when you publish."
|
| 4 |
+
type: dataset
|
| 5 |
+
version: "0.1.3"
|
| 6 |
+
date-released: "2026-10-16"
|
| 7 |
+
license: CC-BY-4.0
|
| 8 |
+
url: "https://ichor.bio/biosimilar-database/"
|
| 9 |
+
doi: 10.5281/zenodo.23350140
|
| 10 |
+
authors:
|
| 11 |
+
- name: "ichorbio"
|
| 12 |
+
website: "https://ichor.bio/"
|
LICENSE.txt
ADDED
|
@@ -0,0 +1,19 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
ichorbio Biosimilar Reference Database — version 0.1.0
|
| 2 |
+
Copyright (c) 2026 ichorbio
|
| 3 |
+
|
| 4 |
+
This dataset is licensed under the Creative Commons Attribution 4.0 International
|
| 5 |
+
License (CC BY 4.0).
|
| 6 |
+
|
| 7 |
+
You are free to:
|
| 8 |
+
- Share — copy and redistribute the material in any medium or format
|
| 9 |
+
- Adapt — remix, transform, and build upon the material
|
| 10 |
+
for any purpose, even commercially.
|
| 11 |
+
|
| 12 |
+
Under the following term:
|
| 13 |
+
- Attribution — You must give appropriate credit to ichorbio, provide a link to
|
| 14 |
+
this licence, and indicate if changes were made.
|
| 15 |
+
|
| 16 |
+
Human-readable summary: https://creativecommons.org/licenses/by/4.0/
|
| 17 |
+
Full legal code: https://creativecommons.org/licenses/by/4.0/legalcode
|
| 18 |
+
|
| 19 |
+
Methods PDFs and page text carry the same CC BY 4.0 licence.
|
README.md
ADDED
|
@@ -0,0 +1,49 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
---
|
| 2 |
+
license: cc-by-4.0
|
| 3 |
+
pretty_name: ichorbio Biosimilar Reference Database
|
| 4 |
+
tags:
|
| 5 |
+
- biology
|
| 6 |
+
- proteins
|
| 7 |
+
- antibodies
|
| 8 |
+
- biosimilars
|
| 9 |
+
- bioinformatics
|
| 10 |
+
- developability
|
| 11 |
+
size_categories:
|
| 12 |
+
- n<1K
|
| 13 |
+
---
|
| 14 |
+
|
| 15 |
+
# ichorbio Biosimilar Reference Database — v0.1.3
|
| 16 |
+
|
| 17 |
+
[](https://doi.org/10.5281/zenodo.23350140)
|
| 18 |
+
|
| 19 |
+
Open, citable developability & biophysical data for ichorbio's research-grade biosimilars.
|
| 20 |
+
Structured per the Developer Brief (Antibodies / Samples / Methods / Measurements; one row per value).
|
| 21 |
+
|
| 22 |
+
## What is in v0.1.3 (seed release)
|
| 23 |
+
- **480 antibodies** — identity, target + UniProt, isotype/format, heavy + light chain
|
| 24 |
+
sequences (from IMGT/mAb-DB), ichorbio SKU, product URL and RRID where assigned.
|
| 25 |
+
- **960 theoretical measurements** — molecular weight and theoretical pI, computed from the
|
| 26 |
+
sequence (marked as theoretical, not laboratory values).
|
| 27 |
+
- **SEC-HPLC purity for 82 biosimilars** from supplier Certificates of Analysis — 68 as the
|
| 28 |
+
exact monomer % read from the CoA chromatogram peak table (280 nm main peak), the rest at a
|
| 29 |
+
>95% specification where no chromatogram is provided.
|
| 30 |
+
|
| 31 |
+
## Added as the supplier's assays arrive (no rebuild needed)
|
| 32 |
+
Further developability data — Tm (DSF), HIC, AC-SINS, PSR, and more SEC-HPLC lots — plus
|
| 33 |
+
raw assay traces. Each new assay is added as rows in `measurements.csv`, never as new columns.
|
| 34 |
+
|
| 35 |
+
## Files
|
| 36 |
+
`antibodies.csv` · `samples.csv` · `methods.csv` · `measurements.csv` · `summary_wide.csv` ·
|
| 37 |
+
`data_dictionary.csv` · `sequences.fasta` · `ichorbio_bsr.json` · `dataset.jsonld` ·
|
| 38 |
+
`CITATION.cff` · `LICENSE.txt` · `llms.txt` · `CHANGELOG.md`
|
| 39 |
+
|
| 40 |
+
## Source & versions
|
| 41 |
+
- GitHub (source repository): https://github.com/ichorbio/biosimilar-reference-database
|
| 42 |
+
- Zenodo (archived, citable): https://doi.org/10.5281/zenodo.23350140
|
| 43 |
+
|
| 44 |
+
## How to cite
|
| 45 |
+
ichorbio (2026). ichorbio Biosimilar Reference Database (version 0.1.3) [Data set].
|
| 46 |
+
Zenodo. https://doi.org/10.5281/zenodo.23350140
|
| 47 |
+
|
| 48 |
+
## Licence
|
| 49 |
+
CC BY 4.0. Data may be reused, including commercially, with attribution to ichorbio.
|
antibodies.csv
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
data_dictionary.csv
ADDED
|
@@ -0,0 +1,44 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
table,field,type,unit,definition,allowed_values
|
| 2 |
+
antibodies,entry_id,string,,Permanent database ID for one molecule (never reused),
|
| 3 |
+
antibodies,inn,string,,WHO International Nonproprietary Name (lower case),
|
| 4 |
+
antibodies,target,string,,Antigen the antibody binds,
|
| 5 |
+
antibodies,target_uniprot,string,,UniProt accession of the target,
|
| 6 |
+
antibodies,format,string,,Antibody format / architecture,
|
| 7 |
+
antibodies,isotype,string,,Heavy-chain isotype + light chain,
|
| 8 |
+
antibodies,host,string,,Host / species origin,
|
| 9 |
+
antibodies,expression_system,string,,Recombinant expression system,CHO / HEK293 / ...
|
| 10 |
+
antibodies,fc_modification,string,,Fc engineering if any,none / LALA / ...
|
| 11 |
+
antibodies,heavy_chain_aa,string,,Heavy chain amino-acid sequence (single letter),
|
| 12 |
+
antibodies,light_chain_aa,string,,Light chain amino-acid sequence (single letter),
|
| 13 |
+
antibodies,sequence_source,string,,Where the sequence came from,IMGT/mAb-DB
|
| 14 |
+
antibodies,imgt_url,url,,IMGT mAb-DB cross-reference,
|
| 15 |
+
antibodies,thera_sabdab_url,url,,Thera-SAbDab cross-reference,
|
| 16 |
+
antibodies,product_sku,string,,ichorbio catalogue number,
|
| 17 |
+
antibodies,product_url,url,,ichorbio product page,
|
| 18 |
+
antibodies,rrid,string,,Antibody Registry RRID,AB_xxxxxxx
|
| 19 |
+
samples,sample_id,string,,ID for one physical lot tested,
|
| 20 |
+
samples,entry_id,string,,Links to antibodies.entry_id,
|
| 21 |
+
samples,sample_type,enum,,Sample type,biosimilar / comparator
|
| 22 |
+
samples,lot_number,string,,Supplier lot number,
|
| 23 |
+
samples,supplier_of_record,string,,Supplier of record for the lot (ichorbio for our products),
|
| 24 |
+
samples,buffer,string,,Formulation / buffer,
|
| 25 |
+
samples,concentration_mg_ml,number,mg/mL,Protein concentration,
|
| 26 |
+
samples,date_received,date,,Date the lot was received,
|
| 27 |
+
methods,method_id,string,,"ID for one assay protocol (new id per change, never edited)",
|
| 28 |
+
methods,assay,string,,Assay name,DSF / SEC-HPLC / HIC-HPLC / AC-SINS / PSR / computed
|
| 29 |
+
methods,instrument,string,,Instrument or 'computed',
|
| 30 |
+
methods,protocol_version,string,,Protocol / method version,
|
| 31 |
+
methods,notes,string,,Free text,
|
| 32 |
+
measurements,measurement_id,string,,ID for one value,
|
| 33 |
+
measurements,sample_id,string,,Links to samples.sample_id,
|
| 34 |
+
measurements,method_id,string,,Links to methods.method_id,
|
| 35 |
+
measurements,parameter,enum,,What was measured,mw_kda / theoretical_pi / tm1 / tm_onset / tagg / pct_monomer / hic_retention_time / acsins_delta_lambda_max / psr_score
|
| 36 |
+
measurements,value,number,per parameter,The value,
|
| 37 |
+
measurements,unit,string,,Unit of the value,kDa / pH units / degC / % / min / nm / score
|
| 38 |
+
measurements,replicate_n,number,,Number of replicates,
|
| 39 |
+
measurements,sd,number,,Standard deviation,
|
| 40 |
+
measurements,measured_on,date,,Date measured,
|
| 41 |
+
measurements,raw_file,path,,Path to the raw trace (CSV) under raw/,
|
| 42 |
+
measurements,first_version,string,,Release this value first appeared in,
|
| 43 |
+
measurements,last_changed_version,string,,Release this value last changed in,
|
| 44 |
+
measurements,notes,string,,"Free text, e.g. a superseded value",
|
dataset.jsonld
ADDED
|
@@ -0,0 +1,95 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"@context": "https://schema.org/",
|
| 3 |
+
"@type": "Dataset",
|
| 4 |
+
"name": "ichorbio Biosimilar Reference Database",
|
| 5 |
+
"description": "Open, citable developability and biophysical data for ichorbio's research-grade biosimilars: identity, sequences, molecular weight and isoelectric point, with measured assay data (Tm, SEC, HIC, AC-SINS, PSR) added over time.",
|
| 6 |
+
"url": "https://ichor.bio/biosimilar-database/",
|
| 7 |
+
"version": "0.1.3",
|
| 8 |
+
"identifier": "https://doi.org/10.5281/zenodo.XXXXXXX",
|
| 9 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 10 |
+
"isAccessibleForFree": true,
|
| 11 |
+
"creator": {
|
| 12 |
+
"@type": "Organization",
|
| 13 |
+
"name": "ichorbio",
|
| 14 |
+
"url": "https://ichor.bio/"
|
| 15 |
+
},
|
| 16 |
+
"datePublished": "2026-10-05",
|
| 17 |
+
"dateModified": "2026-10-05",
|
| 18 |
+
"keywords": [
|
| 19 |
+
"biosimilar",
|
| 20 |
+
"antibody developability",
|
| 21 |
+
"biophysical data",
|
| 22 |
+
"molecular weight",
|
| 23 |
+
"isoelectric point",
|
| 24 |
+
"Tm",
|
| 25 |
+
"SEC-HPLC",
|
| 26 |
+
"HIC",
|
| 27 |
+
"AC-SINS",
|
| 28 |
+
"PSR",
|
| 29 |
+
"reference dataset"
|
| 30 |
+
],
|
| 31 |
+
"measurementTechnique": [
|
| 32 |
+
"Theoretical calculation from sequence",
|
| 33 |
+
"Differential scanning fluorimetry (DSF)",
|
| 34 |
+
"SEC-HPLC",
|
| 35 |
+
"HIC-HPLC",
|
| 36 |
+
"AC-SINS",
|
| 37 |
+
"PSR"
|
| 38 |
+
],
|
| 39 |
+
"variableMeasured": [
|
| 40 |
+
{
|
| 41 |
+
"@type": "PropertyValue",
|
| 42 |
+
"name": "mw_kda",
|
| 43 |
+
"description": "Molecular weight",
|
| 44 |
+
"unitText": "kDa"
|
| 45 |
+
},
|
| 46 |
+
{
|
| 47 |
+
"@type": "PropertyValue",
|
| 48 |
+
"name": "theoretical_pi",
|
| 49 |
+
"description": "Isoelectric point (theoretical)",
|
| 50 |
+
"unitText": "pH units"
|
| 51 |
+
}
|
| 52 |
+
],
|
| 53 |
+
"distribution": [
|
| 54 |
+
{
|
| 55 |
+
"@type": "DataDownload",
|
| 56 |
+
"encodingFormat": "text/csv",
|
| 57 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/antibodies.csv"
|
| 58 |
+
},
|
| 59 |
+
{
|
| 60 |
+
"@type": "DataDownload",
|
| 61 |
+
"encodingFormat": "text/csv",
|
| 62 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/samples.csv"
|
| 63 |
+
},
|
| 64 |
+
{
|
| 65 |
+
"@type": "DataDownload",
|
| 66 |
+
"encodingFormat": "text/csv",
|
| 67 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/methods.csv"
|
| 68 |
+
},
|
| 69 |
+
{
|
| 70 |
+
"@type": "DataDownload",
|
| 71 |
+
"encodingFormat": "text/csv",
|
| 72 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/measurements.csv"
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"@type": "DataDownload",
|
| 76 |
+
"encodingFormat": "text/csv",
|
| 77 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/summary_wide.csv"
|
| 78 |
+
},
|
| 79 |
+
{
|
| 80 |
+
"@type": "DataDownload",
|
| 81 |
+
"encodingFormat": "application/json",
|
| 82 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/ichorbio_bsr.json"
|
| 83 |
+
},
|
| 84 |
+
{
|
| 85 |
+
"@type": "DataDownload",
|
| 86 |
+
"encodingFormat": "text/x-fasta",
|
| 87 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/sequences.fasta"
|
| 88 |
+
},
|
| 89 |
+
{
|
| 90 |
+
"@type": "DataDownload",
|
| 91 |
+
"encodingFormat": "application/vnd.apache.parquet",
|
| 92 |
+
"contentUrl": "https://ichor.bio/biosimilar-database/download/v0.1.3/ichorbio_bsr.parquet"
|
| 93 |
+
}
|
| 94 |
+
]
|
| 95 |
+
}
|
ichorbio_bsr.json
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
llms.txt
ADDED
|
@@ -0,0 +1,22 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# ichorbio Biosimilar Reference Database
|
| 2 |
+
|
| 3 |
+
> Open, citable developability and biophysical data for ichorbio's research-grade biosimilars.
|
| 4 |
+
> Identity, sequences, molecular weight and isoelectric point for 480 antibodies, with measured
|
| 5 |
+
> assay data (Tm, SEC, HIC, AC-SINS, PSR) added over time. Licensed CC BY 4.0.
|
| 6 |
+
|
| 7 |
+
## Start here
|
| 8 |
+
- Home: https://ichor.bio/biosimilar-database/
|
| 9 |
+
- Data dictionary: https://ichor.bio/biosimilar-database/data-dictionary/
|
| 10 |
+
- Methods: https://ichor.bio/biosimilar-database/methods/
|
| 11 |
+
- How to cite: https://ichor.bio/biosimilar-database/#cite
|
| 12 |
+
|
| 13 |
+
## Downloads (machine-readable)
|
| 14 |
+
- CSV tables: https://ichor.bio/biosimilar-database/download/latest/antibodies.csv , samples.csv , methods.csv , measurements.csv
|
| 15 |
+
- Wide summary: https://ichor.bio/biosimilar-database/download/latest/summary_wide.csv
|
| 16 |
+
- JSON (nested by antibody): https://ichor.bio/biosimilar-database/download/latest/ichorbio_bsr.json
|
| 17 |
+
- Parquet: https://ichor.bio/biosimilar-database/download/latest/ichorbio_bsr.parquet
|
| 18 |
+
- Sequences (FASTA): https://ichor.bio/biosimilar-database/download/latest/sequences.fasta
|
| 19 |
+
|
| 20 |
+
## Notes
|
| 21 |
+
- One row per measurement; new assays and antibodies are added as rows, never as new columns.
|
| 22 |
+
- Every value states its method; theoretical values (MW, pI) are marked as computed from sequence.
|
measurements.csv
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
methods.csv
ADDED
|
@@ -0,0 +1,6 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
method_id,assay,instrument,protocol_version,notes
|
| 2 |
+
M-COMP-MW,Molecular weight (theoretical),computed (no instrument),Expasy ProtParam-style: sum of average residue masses + one water per chain,Theoretical value calculated from the amino-acid sequence; not a laboratory measurement.
|
| 3 |
+
M-COMP-PI,Isoelectric point (theoretical),computed (no instrument),Bjellqvist pKa set; bisection over net charge vs pH,Theoretical value calculated from the amino-acid sequence; not a laboratory measurement.
|
| 4 |
+
M-VERIF-MW,Molecular weight (verified value),ichorbio QA / literature,value verified by ichorbio for a complex/bispecific format,Verified value for a multi-chain/bispecific construct where a sum-from-sequence calc is unreliable.
|
| 5 |
+
M-VERIF-PI,Isoelectric point (verified value),ichorbio QA / literature,value verified by ichorbio for a complex/bispecific format,Verified value for a multi-chain/bispecific construct.
|
| 6 |
+
M-SEC-HPLC,Purity (SEC-HPLC),SEC-HPLC (supplier lot-release),BioIntron CoA; size-exclusion HPLC purity,Supplier lot-release purity by size-exclusion HPLC; reported against specification (>95%).
|
samples.csv
ADDED
|
@@ -0,0 +1,481 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
sample_id,entry_id,sample_type,lot_number,supplier_of_record,buffer,concentration_mg_ml,date_received
|
| 2 |
+
S-0001,ICB-BSR-0001,biosimilar,20260212AB05A,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",4,
|
| 3 |
+
S-0002,ICB-BSR-0002,biosimilar,20230802Z002,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",9.32,
|
| 4 |
+
S-0003,ICB-BSR-0003,biosimilar,20240405ZH08,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",11.68,
|
| 5 |
+
S-0004,ICB-BSR-0004,biosimilar,20230801ZH02,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",6.38,
|
| 6 |
+
S-0005,ICB-BSR-0005,biosimilar,20250522AB02,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",9.19,
|
| 7 |
+
S-0006,ICB-BSR-0006,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 8 |
+
S-0007,ICB-BSR-0007,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 9 |
+
S-0008,ICB-BSR-0008,biosimilar,20230724Z004,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",12.19,
|
| 10 |
+
S-0009,ICB-BSR-0009,biosimilar,20240806ZH03,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",6.55,
|
| 11 |
+
S-0010,ICB-BSR-0010,biosimilar,20250915AB02H,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",5.56,
|
| 12 |
+
S-0011,ICB-BSR-0011,biosimilar,20240923Z003,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",18.8,
|
| 13 |
+
S-0012,ICB-BSR-0012,biosimilar,241014,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 14 |
+
S-0013,ICB-BSR-0013,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 15 |
+
S-0014,ICB-BSR-0014,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 16 |
+
S-0015,ICB-BSR-0015,biosimilar,20240415ZH09,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",10.08,
|
| 17 |
+
S-0016,ICB-BSR-0016,biosimilar,20230816ZA01,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",12.47,
|
| 18 |
+
S-0017,ICB-BSR-0017,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 19 |
+
S-0018,ICB-BSR-0018,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 20 |
+
S-0019,ICB-BSR-0019,biosimilar,20250311AB12-A,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",10.35,
|
| 21 |
+
S-0020,ICB-BSR-0020,biosimilar,20230908ZH03,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",10.06,
|
| 22 |
+
S-0021,ICB-BSR-0021,biosimilar,230807-1,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 23 |
+
S-0022,ICB-BSR-0022,biosimilar,20230824ZH01,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",10.71,
|
| 24 |
+
S-0023,ICB-BSR-0023,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 25 |
+
S-0024,ICB-BSR-0024,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 26 |
+
S-0025,ICB-BSR-0025,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 27 |
+
S-0026,ICB-BSR-0026,biosimilar,20230922ZH04,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",13.74,
|
| 28 |
+
S-0027,ICB-BSR-0027,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 29 |
+
S-0028,ICB-BSR-0028,biosimilar,20221221ZA02,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",10.81,
|
| 30 |
+
S-0029,ICB-BSR-0029,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 31 |
+
S-0030,ICB-BSR-0030,biosimilar,20230109ZA06,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",10.59,
|
| 32 |
+
S-0031,ICB-BSR-0031,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 33 |
+
S-0032,ICB-BSR-0032,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 34 |
+
S-0033,ICB-BSR-0033,biosimilar,,ichorbio,"Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.",,
|
| 35 |
+
S-0034,ICB-BSR-0034,biosimilar,20230113Z005,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",16.79,
|
| 36 |
+
S-0035,ICB-BSR-0035,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 37 |
+
S-0036,ICB-BSR-0036,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 38 |
+
S-0037,ICB-BSR-0037,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 39 |
+
S-0038,ICB-BSR-0038,biosimilar,20220913ZA03,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",7.89,
|
| 40 |
+
S-0039,ICB-BSR-0039,biosimilar,20230210Z008,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",13.69,
|
| 41 |
+
S-0040,ICB-BSR-0040,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 42 |
+
S-0041,ICB-BSR-0041,biosimilar,20220909ZA01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",4.09,
|
| 43 |
+
S-0042,ICB-BSR-0042,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 44 |
+
S-0043,ICB-BSR-0043,biosimilar,20230224ZA01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",10.72,
|
| 45 |
+
S-0044,ICB-BSR-0044,biosimilar,20250315AB01-A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",7.8,
|
| 46 |
+
S-0045,ICB-BSR-0045,biosimilar,20240320Z001,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",15.43,
|
| 47 |
+
S-0046,ICB-BSR-0046,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 48 |
+
S-0047,ICB-BSR-0047,biosimilar,20240917ZA06,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",14.4,
|
| 49 |
+
S-0048,ICB-BSR-0048,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 50 |
+
S-0049,ICB-BSR-0049,biosimilar,20250902AB02H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",6.68,
|
| 51 |
+
S-0050,ICB-BSR-0050,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 52 |
+
S-0051,ICB-BSR-0051,biosimilar,M-202505140469,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",2,
|
| 53 |
+
S-0052,ICB-BSR-0052,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 54 |
+
S-0053,ICB-BSR-0053,biosimilar,P0C0DABAH,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",8.74,
|
| 55 |
+
S-0054,ICB-BSR-0054,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 56 |
+
S-0055,ICB-BSR-0055,biosimilar,20230404ZA02,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.42,
|
| 57 |
+
S-0056,ICB-BSR-0056,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 58 |
+
S-0057,ICB-BSR-0057,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 59 |
+
S-0058,ICB-BSR-0058,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 60 |
+
S-0059,ICB-BSR-0059,biosimilar,20230216Z003,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",16.64,
|
| 61 |
+
S-0060,ICB-BSR-0060,biosimilar,20240914ZA04,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",5.79,
|
| 62 |
+
S-0061,ICB-BSR-0061,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 63 |
+
S-0062,ICB-BSR-0062,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 64 |
+
S-0063,ICB-BSR-0063,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 65 |
+
S-0064,ICB-BSR-0064,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 66 |
+
S-0065,ICB-BSR-0065,biosimilar,20230411ZA02,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.4,
|
| 67 |
+
S-0066,ICB-BSR-0066,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 68 |
+
S-0067,ICB-BSR-0067,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 69 |
+
S-0068,ICB-BSR-0068,biosimilar,20241018ZH02,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",11.48,
|
| 70 |
+
S-0069,ICB-BSR-0069,biosimilar,20241023ZH01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",10.5,
|
| 71 |
+
S-0070,ICB-BSR-0070,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 72 |
+
S-0071,ICB-BSR-0071,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 73 |
+
S-0072,ICB-BSR-0072,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 74 |
+
S-0073,ICB-BSR-0073,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 75 |
+
S-0074,ICB-BSR-0074,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 76 |
+
S-0075,ICB-BSR-0075,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 77 |
+
S-0076,ICB-BSR-0076,biosimilar,20240103Z001,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",15.49,
|
| 78 |
+
S-0077,ICB-BSR-0077,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 79 |
+
S-0078,ICB-BSR-0078,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 80 |
+
S-0079,ICB-BSR-0079,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 81 |
+
S-0080,ICB-BSR-0080,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 82 |
+
S-0081,ICB-BSR-0081,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 83 |
+
S-0082,ICB-BSR-0082,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 84 |
+
S-0083,ICB-BSR-0083,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 85 |
+
S-0084,ICB-BSR-0084,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 86 |
+
S-0085,ICB-BSR-0085,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 87 |
+
S-0086,ICB-BSR-0086,biosimilar,20240311ZH05,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",5.46,
|
| 88 |
+
S-0087,ICB-BSR-0087,biosimilar,20230310ZA03,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",7.11,
|
| 89 |
+
S-0088,ICB-BSR-0088,biosimilar,20230114ZA01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.1,
|
| 90 |
+
S-0089,ICB-BSR-0089,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 91 |
+
S-0090,ICB-BSR-0090,biosimilar,20250424AB04,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.28,
|
| 92 |
+
S-0091,ICB-BSR-0091,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 93 |
+
S-0092,ICB-BSR-0092,biosimilar,20240313Z001,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",8.8,
|
| 94 |
+
S-0093,ICB-BSR-0093,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 95 |
+
S-0094,ICB-BSR-0094,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 96 |
+
S-0095,ICB-BSR-0095,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 97 |
+
S-0096,ICB-BSR-0096,biosimilar,20240405ZH07,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",18.86,
|
| 98 |
+
S-0097,ICB-BSR-0097,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 99 |
+
S-0098,ICB-BSR-0098,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 100 |
+
S-0099,ICB-BSR-0099,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 101 |
+
S-0100,ICB-BSR-0100,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 102 |
+
S-0101,ICB-BSR-0101,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 103 |
+
S-0102,ICB-BSR-0102,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 104 |
+
S-0103,ICB-BSR-0103,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 105 |
+
S-0104,ICB-BSR-0104,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 106 |
+
S-0105,ICB-BSR-0105,biosimilar,20250115AB03-A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",19.28,
|
| 107 |
+
S-0106,ICB-BSR-0106,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 108 |
+
S-0107,ICB-BSR-0107,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 109 |
+
S-0108,ICB-BSR-0108,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 110 |
+
S-0109,ICB-BSR-0109,biosimilar,20230510Z002,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",7.06,
|
| 111 |
+
S-0110,ICB-BSR-0110,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 112 |
+
S-0111,ICB-BSR-0111,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 113 |
+
S-0112,ICB-BSR-0112,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 114 |
+
S-0113,ICB-BSR-0113,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 115 |
+
S-0114,ICB-BSR-0114,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 116 |
+
S-0115,ICB-BSR-0115,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 117 |
+
S-0116,ICB-BSR-0116,biosimilar,20250115AB04A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",15.68,
|
| 118 |
+
S-0117,ICB-BSR-0117,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 119 |
+
S-0118,ICB-BSR-0118,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 120 |
+
S-0119,ICB-BSR-0119,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 121 |
+
S-0120,ICB-BSR-0120,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 122 |
+
S-0121,ICB-BSR-0121,biosimilar,,ichorbio,"20mM His/Asp, pH 5.0,Contains no stabilizers or preservatives",,
|
| 123 |
+
S-0122,ICB-BSR-0122,biosimilar,20240415ZH05,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",10.56,
|
| 124 |
+
S-0123,ICB-BSR-0123,biosimilar,20250715AB08H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",14.71,
|
| 125 |
+
S-0124,ICB-BSR-0124,biosimilar,20240716ZH02,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",8.35,
|
| 126 |
+
S-0125,ICB-BSR-0125,biosimilar,20230404ZA04,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",7.89,
|
| 127 |
+
S-0126,ICB-BSR-0126,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 128 |
+
S-0127,ICB-BSR-0127,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 129 |
+
S-0128,ICB-BSR-0128,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 130 |
+
S-0129,ICB-BSR-0129,biosimilar,20250617AB07H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",6.83,
|
| 131 |
+
S-0130,ICB-BSR-0130,biosimilar,20250829AB01H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",5.96,
|
| 132 |
+
S-0131,ICB-BSR-0131,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 133 |
+
S-0132,ICB-BSR-0132,biosimilar,20250311AB09-A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",6.69,
|
| 134 |
+
S-0133,ICB-BSR-0133,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 135 |
+
S-0134,ICB-BSR-0134,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 136 |
+
S-0135,ICB-BSR-0135,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 137 |
+
S-0136,ICB-BSR-0136,biosimilar,20230407ZA03,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",10.22,
|
| 138 |
+
S-0137,ICB-BSR-0137,biosimilar,20240419ZA03,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",11.93,
|
| 139 |
+
S-0138,ICB-BSR-0138,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 140 |
+
S-0139,ICB-BSR-0139,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 141 |
+
S-0140,ICB-BSR-0140,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 142 |
+
S-0141,ICB-BSR-0141,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 143 |
+
S-0142,ICB-BSR-0142,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 144 |
+
S-0143,ICB-BSR-0143,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 145 |
+
S-0144,ICB-BSR-0144,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 146 |
+
S-0145,ICB-BSR-0145,biosimilar,20250117AB01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",19.8,
|
| 147 |
+
S-0146,ICB-BSR-0146,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 148 |
+
S-0147,ICB-BSR-0147,biosimilar,20250625AB07H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",6.15,
|
| 149 |
+
S-0148,ICB-BSR-0148,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 150 |
+
S-0149,ICB-BSR-0149,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 151 |
+
S-0150,ICB-BSR-0150,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 152 |
+
S-0151,ICB-BSR-0151,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 153 |
+
S-0152,ICB-BSR-0152,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 154 |
+
S-0153,ICB-BSR-0153,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 155 |
+
S-0154,ICB-BSR-0154,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 156 |
+
S-0155,ICB-BSR-0155,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 157 |
+
S-0156,ICB-BSR-0156,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 158 |
+
S-0157,ICB-BSR-0157,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 159 |
+
S-0158,ICB-BSR-0158,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 160 |
+
S-0159,ICB-BSR-0159,biosimilar,20220722Z002,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",13.21,
|
| 161 |
+
S-0160,ICB-BSR-0160,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 162 |
+
S-0161,ICB-BSR-0161,biosimilar,20251202AB07H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.81,
|
| 163 |
+
S-0162,ICB-BSR-0162,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 164 |
+
S-0163,ICB-BSR-0163,biosimilar,20240405ZH03,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",17.21,
|
| 165 |
+
S-0164,ICB-BSR-0164,biosimilar,20240405ZH04,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",12.68,
|
| 166 |
+
S-0165,ICB-BSR-0165,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 167 |
+
S-0166,ICB-BSR-0166,biosimilar,20250809AB02H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",15.22,
|
| 168 |
+
S-0167,ICB-BSR-0167,biosimilar,M-202505140471,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",2,
|
| 169 |
+
S-0168,ICB-BSR-0168,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 170 |
+
S-0169,ICB-BSR-0169,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 171 |
+
S-0170,ICB-BSR-0170,biosimilar,20240527ZA01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",7.01,
|
| 172 |
+
S-0171,ICB-BSR-0171,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 173 |
+
S-0172,ICB-BSR-0172,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 174 |
+
S-0173,ICB-BSR-0173,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 175 |
+
S-0174,ICB-BSR-0174,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 176 |
+
S-0175,ICB-BSR-0175,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 177 |
+
S-0176,ICB-BSR-0176,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 178 |
+
S-0177,ICB-BSR-0177,biosimilar,20250630AB01H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",7.47,
|
| 179 |
+
S-0178,ICB-BSR-0178,biosimilar,20250606AB02H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",12.3,
|
| 180 |
+
S-0179,ICB-BSR-0179,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 181 |
+
S-0180,ICB-BSR-0180,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 182 |
+
S-0181,ICB-BSR-0181,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 183 |
+
S-0182,ICB-BSR-0182,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 184 |
+
S-0183,ICB-BSR-0183,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 185 |
+
S-0184,ICB-BSR-0184,biosimilar,20250513AB03-H,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",6.6,
|
| 186 |
+
S-0185,ICB-BSR-0185,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 187 |
+
S-0186,ICB-BSR-0186,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 188 |
+
S-0187,ICB-BSR-0187,biosimilar,M-202505140470,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",2,
|
| 189 |
+
S-0188,ICB-BSR-0188,biosimilar,20250319AB02,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",8.39,
|
| 190 |
+
S-0189,ICB-BSR-0189,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 191 |
+
S-0190,ICB-BSR-0190,biosimilar,20250414AB01-A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",8.04,
|
| 192 |
+
S-0191,ICB-BSR-0191,biosimilar,20250816AB01A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",11.15,
|
| 193 |
+
S-0192,ICB-BSR-0192,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 194 |
+
S-0193,ICB-BSR-0193,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 195 |
+
S-0194,ICB-BSR-0194,biosimilar,20230406ZA01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",10.87,
|
| 196 |
+
S-0195,ICB-BSR-0195,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 197 |
+
S-0196,ICB-BSR-0196,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 198 |
+
S-0197,ICB-BSR-0197,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 199 |
+
S-0198,ICB-BSR-0198,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 200 |
+
S-0199,ICB-BSR-0199,biosimilar,20250516AB01-A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",6.49,
|
| 201 |
+
S-0200,ICB-BSR-0200,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 202 |
+
S-0201,ICB-BSR-0201,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 203 |
+
S-0202,ICB-BSR-0202,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 204 |
+
S-0203,ICB-BSR-0203,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 205 |
+
S-0204,ICB-BSR-0204,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 206 |
+
S-0205,ICB-BSR-0205,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 207 |
+
S-0206,ICB-BSR-0206,biosimilar,20250206AB02,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",6.03,
|
| 208 |
+
S-0207,ICB-BSR-0207,biosimilar,20240430Z003,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.2,
|
| 209 |
+
S-0208,ICB-BSR-0208,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 210 |
+
S-0209,ICB-BSR-0209,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 211 |
+
S-0210,ICB-BSR-0210,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 212 |
+
S-0211,ICB-BSR-0211,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 213 |
+
S-0212,ICB-BSR-0212,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 214 |
+
S-0213,ICB-BSR-0213,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 215 |
+
S-0214,ICB-BSR-0214,biosimilar,20241008Z001,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.47,
|
| 216 |
+
S-0215,ICB-BSR-0215,biosimilar,20240819ZA01,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",11.04,
|
| 217 |
+
S-0216,ICB-BSR-0216,biosimilar,20240430Z005,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",19.17,
|
| 218 |
+
S-0217,ICB-BSR-0217,biosimilar,20231227ZA03,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",8.63,
|
| 219 |
+
S-0218,ICB-BSR-0218,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 220 |
+
S-0219,ICB-BSR-0219,biosimilar,20240906AB02-A,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.75,
|
| 221 |
+
S-0220,ICB-BSR-0220,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 222 |
+
S-0221,ICB-BSR-0221,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 223 |
+
S-0222,ICB-BSR-0222,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 224 |
+
S-0223,ICB-BSR-0223,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 225 |
+
S-0224,ICB-BSR-0224,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 226 |
+
S-0225,ICB-BSR-0225,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 227 |
+
S-0226,ICB-BSR-0226,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 228 |
+
S-0227,ICB-BSR-0227,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 229 |
+
S-0228,ICB-BSR-0228,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 230 |
+
S-0229,ICB-BSR-0229,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 231 |
+
S-0230,ICB-BSR-0230,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 232 |
+
S-0231,ICB-BSR-0231,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 233 |
+
S-0232,ICB-BSR-0232,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 234 |
+
S-0233,ICB-BSR-0233,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 235 |
+
S-0234,ICB-BSR-0234,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 236 |
+
S-0235,ICB-BSR-0235,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 237 |
+
S-0236,ICB-BSR-0236,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 238 |
+
S-0237,ICB-BSR-0237,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 239 |
+
S-0238,ICB-BSR-0238,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 240 |
+
S-0239,ICB-BSR-0239,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 241 |
+
S-0240,ICB-BSR-0240,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 242 |
+
S-0241,ICB-BSR-0241,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 243 |
+
S-0242,ICB-BSR-0242,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 244 |
+
S-0243,ICB-BSR-0243,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 245 |
+
S-0244,ICB-BSR-0244,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 246 |
+
S-0245,ICB-BSR-0245,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 247 |
+
S-0246,ICB-BSR-0246,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 248 |
+
S-0247,ICB-BSR-0247,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 249 |
+
S-0248,ICB-BSR-0248,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 250 |
+
S-0249,ICB-BSR-0249,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 251 |
+
S-0250,ICB-BSR-0250,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 252 |
+
S-0251,ICB-BSR-0251,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 253 |
+
S-0252,ICB-BSR-0252,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 254 |
+
S-0253,ICB-BSR-0253,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 255 |
+
S-0254,ICB-BSR-0254,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 256 |
+
S-0255,ICB-BSR-0255,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 257 |
+
S-0256,ICB-BSR-0256,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 258 |
+
S-0257,ICB-BSR-0257,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 259 |
+
S-0258,ICB-BSR-0258,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 260 |
+
S-0259,ICB-BSR-0259,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 261 |
+
S-0260,ICB-BSR-0260,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 262 |
+
S-0261,ICB-BSR-0261,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 263 |
+
S-0262,ICB-BSR-0262,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 264 |
+
S-0263,ICB-BSR-0263,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 265 |
+
S-0264,ICB-BSR-0264,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 266 |
+
S-0265,ICB-BSR-0265,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 267 |
+
S-0266,ICB-BSR-0266,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 268 |
+
S-0267,ICB-BSR-0267,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 269 |
+
S-0268,ICB-BSR-0268,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 270 |
+
S-0269,ICB-BSR-0269,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 271 |
+
S-0270,ICB-BSR-0270,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 272 |
+
S-0271,ICB-BSR-0271,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 273 |
+
S-0272,ICB-BSR-0272,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 274 |
+
S-0273,ICB-BSR-0273,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 275 |
+
S-0274,ICB-BSR-0274,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 276 |
+
S-0275,ICB-BSR-0275,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 277 |
+
S-0276,ICB-BSR-0276,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 278 |
+
S-0277,ICB-BSR-0277,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 279 |
+
S-0278,ICB-BSR-0278,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 280 |
+
S-0279,ICB-BSR-0279,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 281 |
+
S-0280,ICB-BSR-0280,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 282 |
+
S-0281,ICB-BSR-0281,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 283 |
+
S-0282,ICB-BSR-0282,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 284 |
+
S-0283,ICB-BSR-0283,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 285 |
+
S-0284,ICB-BSR-0284,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 286 |
+
S-0285,ICB-BSR-0285,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 287 |
+
S-0286,ICB-BSR-0286,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 288 |
+
S-0287,ICB-BSR-0287,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 289 |
+
S-0288,ICB-BSR-0288,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 290 |
+
S-0289,ICB-BSR-0289,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 291 |
+
S-0290,ICB-BSR-0290,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 292 |
+
S-0291,ICB-BSR-0291,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 293 |
+
S-0292,ICB-BSR-0292,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 294 |
+
S-0293,ICB-BSR-0293,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 295 |
+
S-0294,ICB-BSR-0294,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 296 |
+
S-0295,ICB-BSR-0295,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 297 |
+
S-0296,ICB-BSR-0296,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 298 |
+
S-0297,ICB-BSR-0297,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 299 |
+
S-0298,ICB-BSR-0298,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 300 |
+
S-0299,ICB-BSR-0299,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 301 |
+
S-0300,ICB-BSR-0300,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 302 |
+
S-0301,ICB-BSR-0301,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 303 |
+
S-0302,ICB-BSR-0302,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 304 |
+
S-0303,ICB-BSR-0303,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 305 |
+
S-0304,ICB-BSR-0304,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 306 |
+
S-0305,ICB-BSR-0305,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 307 |
+
S-0306,ICB-BSR-0306,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 308 |
+
S-0307,ICB-BSR-0307,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 309 |
+
S-0308,ICB-BSR-0308,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 310 |
+
S-0309,ICB-BSR-0309,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 311 |
+
S-0310,ICB-BSR-0310,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 312 |
+
S-0311,ICB-BSR-0311,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 313 |
+
S-0312,ICB-BSR-0312,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 314 |
+
S-0313,ICB-BSR-0313,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 315 |
+
S-0314,ICB-BSR-0314,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 316 |
+
S-0315,ICB-BSR-0315,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 317 |
+
S-0316,ICB-BSR-0316,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 318 |
+
S-0317,ICB-BSR-0317,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 319 |
+
S-0318,ICB-BSR-0318,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 320 |
+
S-0319,ICB-BSR-0319,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 321 |
+
S-0320,ICB-BSR-0320,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 322 |
+
S-0321,ICB-BSR-0321,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 323 |
+
S-0322,ICB-BSR-0322,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 324 |
+
S-0323,ICB-BSR-0323,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 325 |
+
S-0324,ICB-BSR-0324,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 326 |
+
S-0325,ICB-BSR-0325,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 327 |
+
S-0326,ICB-BSR-0326,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 328 |
+
S-0327,ICB-BSR-0327,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 329 |
+
S-0328,ICB-BSR-0328,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 330 |
+
S-0329,ICB-BSR-0329,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 331 |
+
S-0330,ICB-BSR-0330,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 332 |
+
S-0331,ICB-BSR-0331,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 333 |
+
S-0332,ICB-BSR-0332,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 334 |
+
S-0333,ICB-BSR-0333,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 335 |
+
S-0334,ICB-BSR-0334,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 336 |
+
S-0335,ICB-BSR-0335,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 337 |
+
S-0336,ICB-BSR-0336,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 338 |
+
S-0337,ICB-BSR-0337,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 339 |
+
S-0338,ICB-BSR-0338,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 340 |
+
S-0339,ICB-BSR-0339,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 341 |
+
S-0340,ICB-BSR-0340,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 342 |
+
S-0341,ICB-BSR-0341,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 343 |
+
S-0342,ICB-BSR-0342,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 344 |
+
S-0343,ICB-BSR-0343,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 345 |
+
S-0344,ICB-BSR-0344,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 346 |
+
S-0345,ICB-BSR-0345,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 347 |
+
S-0346,ICB-BSR-0346,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 348 |
+
S-0347,ICB-BSR-0347,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 349 |
+
S-0348,ICB-BSR-0348,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 350 |
+
S-0349,ICB-BSR-0349,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 351 |
+
S-0350,ICB-BSR-0350,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 352 |
+
S-0351,ICB-BSR-0351,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 353 |
+
S-0352,ICB-BSR-0352,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 354 |
+
S-0353,ICB-BSR-0353,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 355 |
+
S-0354,ICB-BSR-0354,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 356 |
+
S-0355,ICB-BSR-0355,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 357 |
+
S-0356,ICB-BSR-0356,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 358 |
+
S-0357,ICB-BSR-0357,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 359 |
+
S-0358,ICB-BSR-0358,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 360 |
+
S-0359,ICB-BSR-0359,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 361 |
+
S-0360,ICB-BSR-0360,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 362 |
+
S-0361,ICB-BSR-0361,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 363 |
+
S-0362,ICB-BSR-0362,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 364 |
+
S-0363,ICB-BSR-0363,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 365 |
+
S-0364,ICB-BSR-0364,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 366 |
+
S-0365,ICB-BSR-0365,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 367 |
+
S-0366,ICB-BSR-0366,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 368 |
+
S-0367,ICB-BSR-0367,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 369 |
+
S-0368,ICB-BSR-0368,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 370 |
+
S-0369,ICB-BSR-0369,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 371 |
+
S-0370,ICB-BSR-0370,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 372 |
+
S-0371,ICB-BSR-0371,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 373 |
+
S-0372,ICB-BSR-0372,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 374 |
+
S-0373,ICB-BSR-0373,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 375 |
+
S-0374,ICB-BSR-0374,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 376 |
+
S-0375,ICB-BSR-0375,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 377 |
+
S-0376,ICB-BSR-0376,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 378 |
+
S-0377,ICB-BSR-0377,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 379 |
+
S-0378,ICB-BSR-0378,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 380 |
+
S-0379,ICB-BSR-0379,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 381 |
+
S-0380,ICB-BSR-0380,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 382 |
+
S-0381,ICB-BSR-0381,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 383 |
+
S-0382,ICB-BSR-0382,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 384 |
+
S-0383,ICB-BSR-0383,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 385 |
+
S-0384,ICB-BSR-0384,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 386 |
+
S-0385,ICB-BSR-0385,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 387 |
+
S-0386,ICB-BSR-0386,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 388 |
+
S-0387,ICB-BSR-0387,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 389 |
+
S-0388,ICB-BSR-0388,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 390 |
+
S-0389,ICB-BSR-0389,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 391 |
+
S-0390,ICB-BSR-0390,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 392 |
+
S-0391,ICB-BSR-0391,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 393 |
+
S-0392,ICB-BSR-0392,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 394 |
+
S-0393,ICB-BSR-0393,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 395 |
+
S-0394,ICB-BSR-0394,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 396 |
+
S-0395,ICB-BSR-0395,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 397 |
+
S-0396,ICB-BSR-0396,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 398 |
+
S-0397,ICB-BSR-0397,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 399 |
+
S-0398,ICB-BSR-0398,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 400 |
+
S-0399,ICB-BSR-0399,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 401 |
+
S-0400,ICB-BSR-0400,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 402 |
+
S-0401,ICB-BSR-0401,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 403 |
+
S-0402,ICB-BSR-0402,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 404 |
+
S-0403,ICB-BSR-0403,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 405 |
+
S-0404,ICB-BSR-0404,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 406 |
+
S-0405,ICB-BSR-0405,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 407 |
+
S-0406,ICB-BSR-0406,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 408 |
+
S-0407,ICB-BSR-0407,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 409 |
+
S-0408,ICB-BSR-0408,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 410 |
+
S-0409,ICB-BSR-0409,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 411 |
+
S-0410,ICB-BSR-0410,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 412 |
+
S-0411,ICB-BSR-0411,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 413 |
+
S-0412,ICB-BSR-0412,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 414 |
+
S-0413,ICB-BSR-0413,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 415 |
+
S-0414,ICB-BSR-0414,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 416 |
+
S-0415,ICB-BSR-0415,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 417 |
+
S-0416,ICB-BSR-0416,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 418 |
+
S-0417,ICB-BSR-0417,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 419 |
+
S-0418,ICB-BSR-0418,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 420 |
+
S-0419,ICB-BSR-0419,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 421 |
+
S-0420,ICB-BSR-0420,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 422 |
+
S-0421,ICB-BSR-0421,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 423 |
+
S-0422,ICB-BSR-0422,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 424 |
+
S-0423,ICB-BSR-0423,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 425 |
+
S-0424,ICB-BSR-0424,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 426 |
+
S-0425,ICB-BSR-0425,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 427 |
+
S-0426,ICB-BSR-0426,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 428 |
+
S-0427,ICB-BSR-0427,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 429 |
+
S-0428,ICB-BSR-0428,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 430 |
+
S-0429,ICB-BSR-0429,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 431 |
+
S-0430,ICB-BSR-0430,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 432 |
+
S-0431,ICB-BSR-0431,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 433 |
+
S-0432,ICB-BSR-0432,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 434 |
+
S-0433,ICB-BSR-0433,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 435 |
+
S-0434,ICB-BSR-0434,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 436 |
+
S-0435,ICB-BSR-0435,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 437 |
+
S-0436,ICB-BSR-0436,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 438 |
+
S-0437,ICB-BSR-0437,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 439 |
+
S-0438,ICB-BSR-0438,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 440 |
+
S-0439,ICB-BSR-0439,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 441 |
+
S-0440,ICB-BSR-0440,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 442 |
+
S-0441,ICB-BSR-0441,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 443 |
+
S-0442,ICB-BSR-0442,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 444 |
+
S-0443,ICB-BSR-0443,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 445 |
+
S-0444,ICB-BSR-0444,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 446 |
+
S-0445,ICB-BSR-0445,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 447 |
+
S-0446,ICB-BSR-0446,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 448 |
+
S-0447,ICB-BSR-0447,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 449 |
+
S-0448,ICB-BSR-0448,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 450 |
+
S-0449,ICB-BSR-0449,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 451 |
+
S-0450,ICB-BSR-0450,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 452 |
+
S-0451,ICB-BSR-0451,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 453 |
+
S-0452,ICB-BSR-0452,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 454 |
+
S-0453,ICB-BSR-0453,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 455 |
+
S-0454,ICB-BSR-0454,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 456 |
+
S-0455,ICB-BSR-0455,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 457 |
+
S-0456,ICB-BSR-0456,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 458 |
+
S-0457,ICB-BSR-0457,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 459 |
+
S-0458,ICB-BSR-0458,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 460 |
+
S-0459,ICB-BSR-0459,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 461 |
+
S-0460,ICB-BSR-0460,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 462 |
+
S-0461,ICB-BSR-0461,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 463 |
+
S-0462,ICB-BSR-0462,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 464 |
+
S-0463,ICB-BSR-0463,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 465 |
+
S-0464,ICB-BSR-0464,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 466 |
+
S-0465,ICB-BSR-0465,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 467 |
+
S-0466,ICB-BSR-0466,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 468 |
+
S-0467,ICB-BSR-0467,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 469 |
+
S-0468,ICB-BSR-0468,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 470 |
+
S-0469,ICB-BSR-0469,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 471 |
+
S-0470,ICB-BSR-0470,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 472 |
+
S-0471,ICB-BSR-0471,biosimilar,,ichorbio,"25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)",,
|
| 473 |
+
S-0472,ICB-BSR-0472,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 474 |
+
S-0473,ICB-BSR-0473,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 475 |
+
S-0474,ICB-BSR-0474,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 476 |
+
S-0475,ICB-BSR-0475,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 477 |
+
S-0476,ICB-BSR-0476,biosimilar,B-20250827113,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",9.47,
|
| 478 |
+
S-0477,ICB-BSR-0477,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 479 |
+
S-0478,ICB-BSR-0478,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
| 480 |
+
S-0479,ICB-BSR-0479,biosimilar,20250212AB02-A,ichorbio,,6.83,
|
| 481 |
+
S-0480,ICB-BSR-0480,biosimilar,,ichorbio,"Sterile, preservative-free, solution in PBS. BSA and Azide free.",,
|
sequences.fasta
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
summary_wide.csv
ADDED
|
@@ -0,0 +1,481 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
entry_id,inn,product_sku,target,format,isotype,mw_kda,theoretical_pi
|
| 2 |
+
ICB-BSR-0001,Adalimumab,ICH4001,TNF alpha,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,145.5,8.21
|
| 3 |
+
ICB-BSR-0002,Alemtuzumab,ICH4002,CD52,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,146.1,8.58
|
| 4 |
+
ICB-BSR-0003,Bevacizumab,ICH4003,VEGF,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.6,7.89
|
| 5 |
+
ICB-BSR-0004,Cetuximab,ICH4004,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.07
|
| 6 |
+
ICB-BSR-0005,Eculizumab,ICH4005,Complement protein C5,"standard IgG (2H+2L, theoretical from sequence)",IgG2/4 kappa,145.3,6.21
|
| 7 |
+
ICB-BSR-0006,Infliximab,ICH4006,TNF alpha,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,145.8,7.18
|
| 8 |
+
ICB-BSR-0007,Nimotuzumab,ICH4008,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,147.7,8.07
|
| 9 |
+
ICB-BSR-0008,Nivolumab,ICH4009,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 kappa,143.7,7.67
|
| 10 |
+
ICB-BSR-0009,Omalizumab,ICH4010,IgE,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,146.6,7.17
|
| 11 |
+
ICB-BSR-0010,Rituximab,ICH4011,CD20,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,144.6,8.57
|
| 12 |
+
ICB-BSR-0011,Tocilizumab,ICH4012,IL-6 receptor,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,145.4,8.59
|
| 13 |
+
ICB-BSR-0012,Trastuzumab,ICH4013,HER2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,145.5,8.32
|
| 14 |
+
ICB-BSR-0013,Trastuzumab Deruxtecan,ICH4013D,ERBB2 / HER2 / CD340,"standard IgG (2H+2L, theoretical from sequence)",IgG1,145.5,8.32
|
| 15 |
+
ICB-BSR-0014,Alirocumab,ICH4016,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.0,7.9
|
| 16 |
+
ICB-BSR-0015,Avelumab,ICH4017,PD-L1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 lambda,143.9,8.51
|
| 17 |
+
ICB-BSR-0016,Atezolizumab,ICH4018,PD-L1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,144.6,8.07
|
| 18 |
+
ICB-BSR-0017,Denosumab,ICH4019,RANKL,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,144.8,8.05
|
| 19 |
+
ICB-BSR-0018,Daratumumab,ICH4020,CD38,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,145.4,8.08
|
| 20 |
+
ICB-BSR-0019,Evolocumab,ICH4023,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,141.8,7.65
|
| 21 |
+
ICB-BSR-0020,Ipilimumab,ICH4025,CTLA-4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,145.4,8.43
|
| 22 |
+
ICB-BSR-0021,Obinutuzumab,ICH4026,CD20,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,8.06
|
| 23 |
+
ICB-BSR-0022,Pembrolizumab,ICH4029,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 kappa,146.3,7.4
|
| 24 |
+
ICB-BSR-0023,Pertuzumab,ICH4030,HER2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,167.6,8.49
|
| 25 |
+
ICB-BSR-0024,Ranibizumab,ICH4031,VEGF,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,167.2,8.28
|
| 26 |
+
ICB-BSR-0025,Ramucirumab,ICH4032,VEGFR2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,143.8,8.33
|
| 27 |
+
ICB-BSR-0026,Secukinumab,ICH4033,IL17A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,148.0,7.88
|
| 28 |
+
ICB-BSR-0027,Ustekinumab,ICH4034,IL-12 and IL-23,"standard IgG (2H+2L, theoretical from sequence)",IgG1 kappa,145.7,8.42
|
| 29 |
+
ICB-BSR-0028,Vedolizumab,ICH4035,Integrin alpha 4 + beta 7,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.9,7.89
|
| 30 |
+
ICB-BSR-0029,Sintilimab,ICH5001,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.8,7.11
|
| 31 |
+
ICB-BSR-0030,Toripalimab,ICH5002,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,147.3,6.9
|
| 32 |
+
ICB-BSR-0031,Camrelizumab,ICH5003,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.7,7.06
|
| 33 |
+
ICB-BSR-0032,Tislelizumab,ICH5004,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.1,7.41
|
| 34 |
+
ICB-BSR-0033,Durvalumab,ICH5005,PD-L1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,7.89
|
| 35 |
+
ICB-BSR-0034,Aducanumab,ICH5008,Beta Amyloid,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.0,8.71
|
| 36 |
+
ICB-BSR-0035,Gantenerumab,ICH5009,Beta Amyloid,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.3,8.58
|
| 37 |
+
ICB-BSR-0036,Nesvacumab,ICH5010,Angiopoietin 2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.9,8.07
|
| 38 |
+
ICB-BSR-0037,Belantamab,ICH5011,BCMA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.41
|
| 39 |
+
ICB-BSR-0038,Sutimlimab,ICH5012,C1s,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.9,7.89
|
| 40 |
+
ICB-BSR-0039,Girentuximab,ICH5013,Carbonic Anhydrase IX,bispecific / multi-chain (4 chains),IgG1 - kappa,145.6,8.42
|
| 41 |
+
ICB-BSR-0040,Utomilumab,ICH5014,4-1BB,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,142.8,7.1
|
| 42 |
+
ICB-BSR-0041,Urelumab,ICH5015,4-1BB,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.9,6.59
|
| 43 |
+
ICB-BSR-0042,Atibuclimab,ICH5016,CD14,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.3,7.39
|
| 44 |
+
ICB-BSR-0043,Monalizumab,ICH5017,NKG2A,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.7,7.12
|
| 45 |
+
ICB-BSR-0044,Glofitamab,ICH5019,CD3 + CD20,T-cell engager (TCB) | 2:1 TCB — bivalent tumor + monovalent CD3 | 2 Fabs + 1 CrossFab + heterodimeric Fc (5 chains),Humanized IgG1,194.3,8.2
|
| 46 |
+
ICB-BSR-0045,Daclizumab,ICH5021,IL2RA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.2,8.31
|
| 47 |
+
ICB-BSR-0046,Varlilumab,ICH5022,CD27,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.51
|
| 48 |
+
ICB-BSR-0047,Mosunetuzumab,ICH5026,CD3e + CD20,bispecific / multi-chain (4 chains),IgG1 - kappa,146.3,8.36
|
| 49 |
+
ICB-BSR-0048,Odronextamab,ICH5027,CD3 + CD20,bispecific / multi-chain (3 chains),IgG4 - kappa,122.4,7.66
|
| 50 |
+
ICB-BSR-0049,Isatuximab,ICH5028,CD38,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,7.89
|
| 51 |
+
ICB-BSR-0050,Ibalizumab,ICH5029,CD4,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,147.4,6.81
|
| 52 |
+
ICB-BSR-0051,Dacetuzumab,ICH5030,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.1,8.59
|
| 53 |
+
ICB-BSR-0052,Sotigalimab,ICH5031,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.4,8.46
|
| 54 |
+
ICB-BSR-0053,Selicrelumab,ICH5032,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,146.2,7.84
|
| 55 |
+
ICB-BSR-0054,Lemzoparlimab,ICH5034,CD47,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.6,7.89
|
| 56 |
+
ICB-BSR-0055,Magrolimab,ICH5036,CD47,"standard IgG (2H+2L, theoretical from sequence)",IgG4,145.8,7.67
|
| 57 |
+
ICB-BSR-0056,Cusatuzumab,ICH5037,CD70,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,144.4,6.89
|
| 58 |
+
ICB-BSR-0057,Oleclumab,ICH5038,CD73,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.4,8.22
|
| 59 |
+
ICB-BSR-0058,Polatuzumab,ICH5039,CD79b,"standard IgG (2H+2L, theoretical from sequence)",IgG1,145.3,6.63
|
| 60 |
+
ICB-BSR-0059,Tusamitamab,ICH5040,CEACAM5,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,7.68
|
| 61 |
+
ICB-BSR-0060,Cibisatamab,ICH5041,CEA + CD3,T-cell engager (TCB) | 2:1 TCB — bivalent tumor + monovalent CD3 | 2 Fabs + 1 CrossFab + heterodimeric Fc (5 chains),Humanized IgG1,194.4,8.5
|
| 62 |
+
ICB-BSR-0061,Tinurilimab,ICH5042,CEACAM6,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,144.5,8.18
|
| 63 |
+
ICB-BSR-0062,Erenumab,ICH5043,CGRP receptor,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,146.2,8.48
|
| 64 |
+
ICB-BSR-0063,Eptinezumab,ICH5044,"CALCA, CALCB","standard IgG (2H+2L, theoretical from sequence)",IgG1 N297A-Kappa,143.3,7.65
|
| 65 |
+
ICB-BSR-0064,Fremanezumab,ICH5045,CGRP,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.5,7.39
|
| 66 |
+
ICB-BSR-0065,Galcanezumab,ICH5046,CGRP,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P/F234A/L235A/KDel)-Kappa,144.1,7.66
|
| 67 |
+
ICB-BSR-0066,Zolbetuximab,ICH5047,Claudin 18.2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 K97R-Kappa,147.1,8.31
|
| 68 |
+
ICB-BSR-0067,Rovalpituzumab,ICH5048,DLL3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.8,7.4
|
| 69 |
+
ICB-BSR-0068,Batoclimab,ICH5049,FcRn,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Lambda2,143.5,7.9
|
| 70 |
+
ICB-BSR-0069,Nipocalimab,ICH5050,FcRn,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda3,141.8,8.07
|
| 71 |
+
ICB-BSR-0070,Rozanolixizumab,ICH5051,FcRn,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.2,7.67
|
| 72 |
+
ICB-BSR-0071,Aprutumab,ICH5052,FGFR2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,144.6,7.9
|
| 73 |
+
ICB-BSR-0072,Bemarituzumab,ICH5053,FGFR2b,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,143.9,8.32
|
| 74 |
+
ICB-BSR-0073,Mavrilimumab,ICH5054,GM-CSF,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - lambda2,143.2,6.31
|
| 75 |
+
ICB-BSR-0074,Codrituzumab,ICH5055,GPC3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.31
|
| 76 |
+
ICB-BSR-0075,Margetuximab,ICH5057,HER2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.9,8.07
|
| 77 |
+
ICB-BSR-0076,Lebrikizumab,ICH5058,IL-13,"standard IgG (2H+2L, theoretical from sequence)",IgG4 S228P-Kappa,145.3,6.41
|
| 78 |
+
ICB-BSR-0077,Tralokinumab,ICH5059,IL-13,"standard IgG (2H+2L, theoretical from sequence)",IgG4 S228P-Kappa,144.2,6.81
|
| 79 |
+
ICB-BSR-0078,Brodalumab,ICH5060,IL-17RA,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,144.1,8.19
|
| 80 |
+
ICB-BSR-0079,Etokimab,ICH5061,IL-33,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.6,8.7
|
| 81 |
+
ICB-BSR-0080,Dupilumab,ICH5062,IL-4R alpha,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.9,6.78
|
| 82 |
+
ICB-BSR-0081,Clazakizumab,ICH5063,IL-6,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,7.67
|
| 83 |
+
ICB-BSR-0082,Guselkumab,ICH5064,IL-23,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Lambda3,143.6,8.32
|
| 84 |
+
ICB-BSR-0083,Simtuzumab,ICH5068,LOXL2,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.4,7.67
|
| 85 |
+
ICB-BSR-0084,Amatuximab,ICH5069,MSLN,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.4,8.2
|
| 86 |
+
ICB-BSR-0085,Enfortumab Vedotin,ICH5070V,Nectin-4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.1,8.21
|
| 87 |
+
ICB-BSR-0086,Sacituzumab,ICH5076,TACSTD2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.31
|
| 88 |
+
ICB-BSR-0087,Fresolimumab,ICH5077,TGF beta 1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 S228P-Kappa,144.4,6.55
|
| 89 |
+
ICB-BSR-0088,Tiragolumab,ICH5078,TIGIT,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,148.7,7.88
|
| 90 |
+
ICB-BSR-0089,Sabatolimab,ICH5079,Tim-3,"standard IgG (2H+2L, theoretical from sequence)",IgG4 S228P-Kappa,144.7,7.39
|
| 91 |
+
ICB-BSR-0090,Belimumab,ICH5080,BAFF,"standard IgG (2H+2L, theoretical from sequence)","IgG1 E239D ,M241L-lambda3 K83R",144.1,8.08
|
| 92 |
+
ICB-BSR-0091,Onvatilimab,ICH5081,VISTA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.9,8.21
|
| 93 |
+
ICB-BSR-0092,Rosopatamab,ICH5083,PMSA,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,144.4,7.14
|
| 94 |
+
ICB-BSR-0093,Rolinsatamab,ICH5084,PRLR,"standard IgG (2H+2L, theoretical from sequence)",IgG1(S239C)-Kappa,145.6,8.18
|
| 95 |
+
ICB-BSR-0094,Iratumumab,ICH5085,CD30,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L/436YDel)-Kappa,143.0,8.21
|
| 96 |
+
ICB-BSR-0095,Sofituzumab Vedotin,ICH5086V,CA125 / MUC16,"standard IgG (2H+2L, theoretical from sequence)",IgG1,144.8,8.06
|
| 97 |
+
ICB-BSR-0096,Nadunolimab,ICH5088,IL1RAP,"standard IgG (2H+2L, theoretical from sequence)",IgG1(KDel)-Kappa,144.3,7.68
|
| 98 |
+
ICB-BSR-0097,Pivekimab,ICH5089,IL-3RA,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L/S442C/KDel)-Kappa,146.0,8.04
|
| 99 |
+
ICB-BSR-0098,Camidanlumab,ICH5090,IL2RA,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R/E356D/M358L)-Kappa,144.1,8.51
|
| 100 |
+
ICB-BSR-0099,Indusatumab,ICH5091,GC-C,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,145.2,8.59
|
| 101 |
+
ICB-BSR-0100,Edrecolomab,ICH5092,CD326,"standard IgG (2H+2L, theoretical from sequence)",Mouse IgG2a-kappa,144.2,8.2
|
| 102 |
+
ICB-BSR-0101,Pinatuzumab Vedotin,ICH5093V,Siglec-2 / CD22,"standard IgG (2H+2L, theoretical from sequence)",IgG1,146.7,8.21
|
| 103 |
+
ICB-BSR-0102,Upifitamab,ICH5094,SLC34A2,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R/E356D/M358L)-Kappa,145.1,8.41
|
| 104 |
+
ICB-BSR-0103,Omburtamab,ICH5095,CD276,"standard IgG (2H+2L, theoretical from sequence)",Mouse IgG1-Kappa,144.7,6.3
|
| 105 |
+
ICB-BSR-0104,Daxdilimab,ICH5096,ILT-7,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Lambda2(K83R）,144.4,8.32
|
| 106 |
+
ICB-BSR-0105,Mirvetuximab,ICH5097,FOLR1,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L/KDel)-Kappa,145.7,7.68
|
| 107 |
+
ICB-BSR-0106,Ieramilimab,ICH5098,LAG3,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P/KDel)-Kappa,146.6,6.26
|
| 108 |
+
ICB-BSR-0107,Veltuzumab,ICH5099,CD20,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,145.4,8.2
|
| 109 |
+
ICB-BSR-0108,Tovetumab,ICH5100,PDGFR alpha,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,144.8,8.3
|
| 110 |
+
ICB-BSR-0109,Teplizumab,ICH5101,CD3E,"standard IgG (2H+2L, theoretical from sequence)",IgG1(L234A/L235A/E356D/M358L)-Kappa,145.8,8.56
|
| 111 |
+
ICB-BSR-0110,Tanezumab,ICH5102,NGF,"standard IgG (2H+2L, theoretical from sequence)",IgG2(A330S/P331S)-Kappa,145.5,7.65
|
| 112 |
+
ICB-BSR-0111,Tabalumab,ICH5103,BAFF,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa(S70N),146.3,7.89
|
| 113 |
+
ICB-BSR-0112,Siltuximab,ICH5104,IL-6,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,145.0,8.06
|
| 114 |
+
ICB-BSR-0113,Sifalimumab,ICH5105,Interferon Alpha 1,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Kappa,144.3,8.51
|
| 115 |
+
ICB-BSR-0114,Satralizumab,ICH5106,IL-6R,"standard IgG (2H+2L, theoretical from sequence)",IgG2(C131S/R133K/E137G/C219S/H264Q/R351Q/S374A/Q415E/N430A)-Kappa,143.4,5.92
|
| 116 |
+
ICB-BSR-0115,Sarilumab,ICH5107,IL-6R,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,144.2,8.08
|
| 117 |
+
ICB-BSR-0116,Romosozumab,ICH5108,SOST,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,145.9,6.62
|
| 118 |
+
ICB-BSR-0117,Robatumumab,ICH5109,IGF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,144.6,8.52
|
| 119 |
+
ICB-BSR-0118,Rilotumumab,ICH5110,HGF,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,145.2,7.87
|
| 120 |
+
ICB-BSR-0119,Ponezumab,ICH5111,APP,"standard IgG (2H+2L, theoretical from sequence)",IgG2(A330S/P331S)-Kappa,145.7,8.04
|
| 121 |
+
ICB-BSR-0120,Penpulimab,ICH5112,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG1(L234A/L235A/G237A/E356D/M358L)-Kappa,145.0,8.21
|
| 122 |
+
ICB-BSR-0121,Vudalimab,ICH5113,PD-1 + CTLA-4,"Dual checkpoint inhibitor (NOT a T-cell engager) | Asymmetric — 1 Fab + 1 scFv, both monovalent | Fab (H+L) + scFv-Fc + heterodimeric Fc (3 chains)",IgG1 (Xencor XmAb Fc),125.4,8.5
|
| 123 |
+
ICB-BSR-0122,Farletuzumab,ICH5114,FOLR1,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,145.4,8.07
|
| 124 |
+
ICB-BSR-0123,Canakinumab,ICH5115,IL1B,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,145.2,8.07
|
| 125 |
+
ICB-BSR-0124,Relatlimab,ICH5117,LAG3,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,145.4,6.59
|
| 126 |
+
ICB-BSR-0125,Ivuxolimab,ICH5119,OX40,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,144.2,6.81
|
| 127 |
+
ICB-BSR-0126,Necitumumab,ICH5121,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1(F126L/K214R)-Kappa,144.9,8.07
|
| 128 |
+
ICB-BSR-0127,Tilvestamab,ICH5122,Axl,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Kappa,146.3,8.5
|
| 129 |
+
ICB-BSR-0128,Nemolizumab,ICH5123,IL-31RA,"standard IgG (2H+2L, theoretical from sequence)",IgG2(C130S/R132K/E136G/S137G/C218S/H263Q/R350Q/Q414E/G441DEL/K442DEL)-Kappa,144.2,5.86
|
| 130 |
+
ICB-BSR-0129,Enoblituzumab,ICH5124,CD276,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R/L235V/ F243L/R292P/Y300L/P396L)-Kappa,145.9,8.06
|
| 131 |
+
ICB-BSR-0130,Tilavonemab,ICH5125,Tau,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,145.8,6.56
|
| 132 |
+
ICB-BSR-0131,Zagotenemab,ICH5126,Tau,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P/F234A/L235A/K447Del)-Kappa,145.3,7.11
|
| 133 |
+
ICB-BSR-0132,Teprotumumab,ICH5128,IGF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,145.7,8.6
|
| 134 |
+
ICB-BSR-0133,Lucatumumab,ICH5129,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG1(S131A/K214R)-Kappa,146.2,8.08
|
| 135 |
+
ICB-BSR-0134,Anifrolumab,ICH5130,IFNAR1,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R/L351F/L352E/P448S)-Kappa,145.2,7.67
|
| 136 |
+
ICB-BSR-0135,Uliledlimab,ICH5131,NT5E,"standard IgG (2H+2L, theoretical from sequence)",IgG1(N297A)-Kappa,145.1,8.06
|
| 137 |
+
ICB-BSR-0136,Tafasitamab,ICH5132,CD19,"standard IgG (2H+2L, theoretical from sequence)",IgG1(S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa,147.5,7.14
|
| 138 |
+
ICB-BSR-0137,Gevokizumab,ICH5133,IL-1B,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.0,7.88
|
| 139 |
+
ICB-BSR-0138,Enibarcimab,ICH5134,ADM,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,146.3,7.67
|
| 140 |
+
ICB-BSR-0139,Mupadolimab,ICH5136,CD73,"standard IgG (2H+2L, theoretical from sequence)",IgG1(N297Q/E356D/M358L)-Kappa,147.0,7.14
|
| 141 |
+
ICB-BSR-0140,Brentuximab Vedotin,ICH5137V,TNFRSF8 / CD30,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,6.66
|
| 142 |
+
ICB-BSR-0141,Abituzumab,ICH5138,CD51,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.2,7.42
|
| 143 |
+
ICB-BSR-0142,Abrilumab,ICH5139,ITGA4 + ITGB7,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,143.8,6.45
|
| 144 |
+
ICB-BSR-0143,Bapineuzumab,ICH5140,APP,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Kappa,145.7,8.32
|
| 145 |
+
ICB-BSR-0144,Blosozumab,ICH5141,SOST,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P/KDel)-Kappa,144.7,6.18
|
| 146 |
+
ICB-BSR-0145,Bococizumab,ICH5142,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG2(A330S/P331S)-Kappa,145.1,8.47
|
| 147 |
+
ICB-BSR-0146,Carlumab,ICH5143,CCL2,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,144.9,7.42
|
| 148 |
+
ICB-BSR-0147,Cixutumumab,ICH5144,IGF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Kappa,146.4,8.2
|
| 149 |
+
ICB-BSR-0148,Efalizumab,ICH5145,CD11a,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Kappa,146.2,8.41
|
| 150 |
+
ICB-BSR-0149,Eldelumab,ICH5146,CXCL10,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,146.8,8.07
|
| 151 |
+
ICB-BSR-0150,Emapalumab,ICH5147,IFN-gamma,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,145.4,7.68
|
| 152 |
+
ICB-BSR-0151,Emibetuzumab,ICH5148,MET,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P/F234A/L235A/KDel)-Kappa,143.8,7.89
|
| 153 |
+
ICB-BSR-0152,Enokizumab,ICH5149,IL-9,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,146.0,7.67
|
| 154 |
+
ICB-BSR-0153,Etrolizumab,ICH5150,ITGA4 + ITGB7,"standard IgG (2H+2L, theoretical from sequence)",IgG1(KDel)-Kappa,144.2,8.07
|
| 155 |
+
ICB-BSR-0154,Evinacumab,ICH5151,ANGPTL3,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,146.1,6.78
|
| 156 |
+
ICB-BSR-0155,Fasinumab,ICH5152,NGF,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,144.9,6.59
|
| 157 |
+
ICB-BSR-0156,Ficlatuzumab,ICH5153,HGF,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,145.4,7.68
|
| 158 |
+
ICB-BSR-0157,Figitumumab,ICH5154,IGF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG2(KDel)-Kappa,145.8,7.86
|
| 159 |
+
ICB-BSR-0158,Fletikumab,ICH5155,IL-20,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,146.5,6.63
|
| 160 |
+
ICB-BSR-0159,Foralumab,ICH5156,CD3E,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Kappa,145.7,8.59
|
| 161 |
+
ICB-BSR-0160,Fulranumab,ICH5157,NGF,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,145.4,7.4
|
| 162 |
+
ICB-BSR-0161,Zilovertamab,ICH5158,ROR1,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,145.2,7.16
|
| 163 |
+
ICB-BSR-0162,Vibostolimab,ICH5159,TIGIT,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,145.3,8.2
|
| 164 |
+
ICB-BSR-0163,Burosumab,ICH5160,FGF23,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,144.1,8.07
|
| 165 |
+
ICB-BSR-0164,Cemiplimab,ICH5161,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,143.9,7.09
|
| 166 |
+
ICB-BSR-0165,Glembatumumab,ICH5163,GPNMB,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,145.3,7.87
|
| 167 |
+
ICB-BSR-0166,Naxitamab,ICH5164,Ganglioside GD2,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R/E356D/M358L)-Kappa,144.5,8.33
|
| 168 |
+
ICB-BSR-0167,Ixekizumab,ICH5165,IL-17A,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,146.2,7.69
|
| 169 |
+
ICB-BSR-0168,Lenzilumab,ICH5166,CSF2,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,145.9,8.77
|
| 170 |
+
ICB-BSR-0169,Lirilumab,ICH5167,KIR2DL1,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,145.6,6.78
|
| 171 |
+
ICB-BSR-0170,Inebilizumab,ICH5168,CD19,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,146.7,7.13
|
| 172 |
+
ICB-BSR-0171,Motavizumab,ICH5169,RSV,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,145.5,8.32
|
| 173 |
+
ICB-BSR-0172,Olokizumab,ICH5170,IL-6,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P)-Kappa,145.4,6.41
|
| 174 |
+
ICB-BSR-0173,Otelixizumab,ICH5171,CD3E,"standard IgG (2H+2L, theoretical from sequence)",IgG1(N297A/E356D/M358L)-Lambda2(K83R),145.2,8.07
|
| 175 |
+
ICB-BSR-0174,Ozanezumab,ICH5173,NOGO-A,"standard IgG (2H+2L, theoretical from sequence)",IgG1(L235A/G237A/E356D/M358L)-Kappa,145.2,8.41
|
| 176 |
+
ICB-BSR-0175,Panobacumab,ICH5174,Pseudomonas aeruginosa serotype IATS O11,"IgM (pentamer; 5x[2H+2L]+J-chain, theoretical)",IgM-Kappa,864.3,6.9
|
| 177 |
+
ICB-BSR-0176,Parsatuzumab,ICH5175,EGFL7,"standard IgG (2H+2L, theoretical from sequence)",IgG1-Kappa,147.9,8.07
|
| 178 |
+
ICB-BSR-0177,Fezakinumab,ICH5176,IL-22,"standard IgG (2H+2L, theoretical from sequence)",IgG1(KDel)- Lambda 2(K83R),144.6,7.9
|
| 179 |
+
ICB-BSR-0178,Emicizumab,ICH5178,Factor IX + Factor X,bispecific / multi-chain (4 chains),IgG4 mutation-kappa,145.7,6.46
|
| 180 |
+
ICB-BSR-0179,Ozuriftamab,ICH5179,ROR2,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L/KDel)-Kappa,145.0,8.2
|
| 181 |
+
ICB-BSR-0180,Bamlanivimab,ICH5180,SARS-CoV-2,"standard IgG (2H+2L, theoretical from sequence)",IgG1(K214R)-Kappa,146.5,8.64
|
| 182 |
+
ICB-BSR-0181,Ponsegromab,ICH5182,GDF15,"standard IgG (2H+2L, theoretical from sequence)",IgG1(L234A/L235A/G237A/KDel)-Kappa,145.1,7.14
|
| 183 |
+
ICB-BSR-0182,Lusvertikimab,ICH5183,IL-7RA,"standard IgG (2H+2L, theoretical from sequence)",IgG4(S228P/L445P)-Kappa,145.7,7.4
|
| 184 |
+
ICB-BSR-0183,Tremelimumab,ICH5184,CTLA-4,"standard IgG (2H+2L, theoretical from sequence)",IgG2 kappa,146.4,8.04
|
| 185 |
+
ICB-BSR-0184,Mogamulizumab,ICH5186,CCR4,"standard IgG (2H+2L, theoretical from sequence)",IgG1κ,146.5,8.07
|
| 186 |
+
ICB-BSR-0185,Oxelumab,ICH5187,CD37,"standard IgG (2H+2L, theoretical from sequence)",IgG1CH2+CH3(E356D/M358L)-Kappa,144.6,8.07
|
| 187 |
+
ICB-BSR-0186,Briakinumab,ICH5188,CD30,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,144.0,8.65
|
| 188 |
+
ICB-BSR-0187,Elotuzumab,ICH5202,SLAMF7,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.5,7.67
|
| 189 |
+
ICB-BSR-0188,Patritumab,ICH5206,HER3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.0,8.21
|
| 190 |
+
ICB-BSR-0189,Patritumab Deruxtecan,ICH5206D,ERBB3 / HER3,"standard IgG (2H+2L, theoretical from sequence)",IgG1,147.0,8.21
|
| 191 |
+
ICB-BSR-0190,Talquetamab,ICH5207,CD3 + GPRC5D,bispecific / multi-chain (4 chains),,144.6,8.47
|
| 192 |
+
ICB-BSR-0191,Teclistamab,ICH5209,CD3 + BCMA,bispecific / multi-chain (4 chains),IgG4 - lambda,143.7,7.9
|
| 193 |
+
ICB-BSR-0192,Risankizumab,ICH5210,IL-23α,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.32
|
| 194 |
+
ICB-BSR-0193,Onartuzumab,ICH5212,MET,Fab fragment (1 H-fragment + 1 L),(Fab - G1 - kappa) - (Fc - G1),73.5,8.2
|
| 195 |
+
ICB-BSR-0194,Tezepelumab,ICH5213,TSLP,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,144.6,7.17
|
| 196 |
+
ICB-BSR-0195,Prezalumab,ICH5214,B7H2,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.4,7.38
|
| 197 |
+
ICB-BSR-0196,Ganitumab,ICH5216,IGF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,8.21
|
| 198 |
+
ICB-BSR-0197,Datopotamab Deruxtecan,ICH5217D,TROP2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,8.41
|
| 199 |
+
ICB-BSR-0198,Lecanemab,ICH5219,Amyloid Beta,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.2,8.32
|
| 200 |
+
ICB-BSR-0199,Amivantamab,ICH5222,EGFR + MET,bispecific / multi-chain (4 chains),IgG1 - kappa,145.9,8.21
|
| 201 |
+
ICB-BSR-0200,Tisotumab,ICH5293,CD142,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.8,8.21
|
| 202 |
+
ICB-BSR-0201,Tisotumab Vedotin,ICH5293V,TF / Factor III / Tissue Factor / CD142,"standard IgG (2H+2L, theoretical from sequence)",IgG1,144.8,8.21
|
| 203 |
+
ICB-BSR-0202,Depatuxizumab,ICH5294,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,8.32
|
| 204 |
+
ICB-BSR-0203,Pozelimab,ICH5295,C5,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.8,7.38
|
| 205 |
+
ICB-BSR-0204,Retifanlimab,ICH5296,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.4,6.35
|
| 206 |
+
ICB-BSR-0205,Ublituximab,ICH5297,CD20,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.5,8.57
|
| 207 |
+
ICB-BSR-0206,Loncastuximab,ICH5298,CD19,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.7,8.06
|
| 208 |
+
ICB-BSR-0207,Crizanlizumab,ICH5300,SELP,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,146.3,6.46
|
| 209 |
+
ICB-BSR-0208,Lanadelumab,ICH5302,KLKB1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,8.33
|
| 210 |
+
ICB-BSR-0209,Tildrakizumab,ICH5303,IL-23A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.5,8.2
|
| 211 |
+
ICB-BSR-0210,Bezlotoxumab,ICH5304,Toxin B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.51
|
| 212 |
+
ICB-BSR-0211,Olaratumab,ICH5305,CD140a,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.3,8.21
|
| 213 |
+
ICB-BSR-0212,Obiltoxaximab,ICH5306,Anthrax PA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.42
|
| 214 |
+
ICB-BSR-0213,Idarucizumab,ICH5307,Pradaxa,Fab fragment (1 H-fragment + 1 L),Fab - G1 - kappa,47.8,8.56
|
| 215 |
+
ICB-BSR-0214,Dinutuximab,ICH5308,Ganglioside GD2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.0,8.42
|
| 216 |
+
ICB-BSR-0215,Dostarlimab,ICH5311,PD-1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.2,6.84
|
| 217 |
+
ICB-BSR-0216,Benralizumab,ICH5313,IL-5RA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.41
|
| 218 |
+
ICB-BSR-0217,Telisotuzumab,ICH5315,MET,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.5,7.41
|
| 219 |
+
ICB-BSR-0218,Telisotuzumab Vedotin,ICH5315V,HGFR / c-Met,"standard IgG (2H+2L, theoretical from sequence)",IgG1,145.5,7.41
|
| 220 |
+
ICB-BSR-0219,Ravulizumab,ICH5317,Complement C5,"standard IgG (2H+2L, theoretical from sequence)",IgG2-G4 - kappa,145.3,6.31
|
| 221 |
+
ICB-BSR-0220,Epcoritamab,ICH5319,CD3E + CD20,bispecific / multi-chain (4 chains),Ig(G1 - kappa_G1 - lambda2),145.7,8.28
|
| 222 |
+
ICB-BSR-0221,Faricimab,ICH5320,ANGPT2 + VEGFA,"Dual angiogenesis inhibitor (NOT a T-cell engager) | 1:1 bispecific IgG — 1 Fab per target, both monovalent | 2 Fabs (1 normal + 1 CrossMab) + heterodimeric Fc (4 chains)",Humanized IgG1,144.9,7.8
|
| 223 |
+
ICB-BSR-0222,Abagovomab,ICH5321,CA 125,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.5,7.19
|
| 224 |
+
ICB-BSR-0223,Abelacimab,ICH5322,F11,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,144.4,8.33
|
| 225 |
+
ICB-BSR-0224,Abrezekimab,ICH5324,IL13,Fab fragment (1 H-fragment + 1 L),Fab - G1 - kappa,47.3,8.14
|
| 226 |
+
ICB-BSR-0225,Actoxumab,ICH5326,toxin A [Clostridioides difficile],"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.9,8.22
|
| 227 |
+
ICB-BSR-0226,Afasevikumab,ICH5330,IL17A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.22
|
| 228 |
+
ICB-BSR-0227,Alsevalimab,ICH5339,VTCN1,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,144.8,8.42
|
| 229 |
+
ICB-BSR-0228,Andecaliximab,ICH5345,MMP9,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.9,7.4
|
| 230 |
+
ICB-BSR-0229,Anrukinzumab,ICH5347,IL13,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,7.89
|
| 231 |
+
ICB-BSR-0230,Ascrinvacumab,ICH5355,ACVRL1,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,144.4,7.65
|
| 232 |
+
ICB-BSR-0231,Astegolimab,ICH5356,IL1RL1,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.0,6.45
|
| 233 |
+
ICB-BSR-0232,Atidortoxumab,ICH5359,alpha toxin,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,143.8,8.21
|
| 234 |
+
ICB-BSR-0233,Atinumab,ICH5361,RTN4,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.7,7.67
|
| 235 |
+
ICB-BSR-0234,Atoltivimab,ICH5362,Zaire Ebola virus,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.1,8.33
|
| 236 |
+
ICB-BSR-0235,Avdoralimab,ICH5364,C5AR1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.0,8.2
|
| 237 |
+
ICB-BSR-0236,Avizakimab,ICH5365,IL21,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,8.2
|
| 238 |
+
ICB-BSR-0237,Axatilimab,ICH5366,CSF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,147.2,6.21
|
| 239 |
+
ICB-BSR-0238,Azintuxizumab,ICH5367,SLAMF7,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.07
|
| 240 |
+
ICB-BSR-0239,Balstilimab,ICH5369,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.4,8.08
|
| 241 |
+
ICB-BSR-0240,Bavituximab,ICH5376,phosphatidylserine [Homo sapiens],"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,7.42
|
| 242 |
+
ICB-BSR-0241,Bedinvetmab,ICH5380,NGF,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,145.7,6.74
|
| 243 |
+
ICB-BSR-0242,Befovacimab,ICH5381,TFPI,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,143.0,7.65
|
| 244 |
+
ICB-BSR-0243,Begelomab,ICH5382,DPP4,"standard IgG (2H+2L, theoretical from sequence)",IgG2b - kappa,146.3,8.04
|
| 245 |
+
ICB-BSR-0244,Benufutamab,ICH5390,TNFRSF10B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.9,8.21
|
| 246 |
+
ICB-BSR-0245,Bepranemab,ICH5391,MAPT,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.0,6.18
|
| 247 |
+
ICB-BSR-0246,Berlimatoxumab,ICH5392,LukGH,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,8.2
|
| 248 |
+
ICB-BSR-0247,Bermekimab,ICH5393,IL1A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.5,8.52
|
| 249 |
+
ICB-BSR-0248,Bersanlimab,ICH5394,ICAM1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,144.3,8.07
|
| 250 |
+
ICB-BSR-0249,Bimagrumab,ICH5402,ACVR2B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,142.8,8.65
|
| 251 |
+
ICB-BSR-0250,Bimekizumab,ICH5403,IL17A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.3,8.07
|
| 252 |
+
ICB-BSR-0251,Birtamimab,ICH5404,SAA1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.6,8.32
|
| 253 |
+
ICB-BSR-0252,Bleselumab,ICH5407,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.2,7.89
|
| 254 |
+
ICB-BSR-0253,Blontuvetmab,ICH5409,MS4A1,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - Vkappa-Clambda,145.4,7.42
|
| 255 |
+
ICB-BSR-0254,Brazikumab,ICH5413,IL23A,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,144.9,7.12
|
| 256 |
+
ICB-BSR-0255,Brontictuzumab,ICH5416,NOTCH1,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,144.0,8.39
|
| 257 |
+
ICB-BSR-0256,Budigalimab,ICH5417,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.8,6.75
|
| 258 |
+
ICB-BSR-0257,Cabiralizumab,ICH5419,CSF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.3,6.02
|
| 259 |
+
ICB-BSR-0258,Carotuximab,ICH5428,ENG,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.8,8.32
|
| 260 |
+
ICB-BSR-0259,Cendakimab,ICH5432,IL13,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,8.41
|
| 261 |
+
ICB-BSR-0260,Cetrelimab,ICH5434,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.1,7.06
|
| 262 |
+
ICB-BSR-0261,Cinpanemab,ICH5439,SNCA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,142.2,6.53
|
| 263 |
+
ICB-BSR-0262,Cobolimab,ICH5442,HAVCR2,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,142.9,7.67
|
| 264 |
+
ICB-BSR-0263,Cofetuzumab,ICH5443,PTK7,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.5,7.68
|
| 265 |
+
ICB-BSR-0264,Conatumumab,ICH5445,TNFRSF10B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,8.33
|
| 266 |
+
ICB-BSR-0265,Concizumab,ICH5447,TFPI,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.9,6.27
|
| 267 |
+
ICB-BSR-0266,Cosfroviximab,ICH5450,Zaire Ebola virus,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.1,7.67
|
| 268 |
+
ICB-BSR-0267,Cosibelimab,ICH5451,PD-L1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,144.7,7.68
|
| 269 |
+
ICB-BSR-0268,Crenezumab,ICH5454,APP,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.4,6.63
|
| 270 |
+
ICB-BSR-0269,Crotedumab,ICH5456,GCGR,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,147.0,6.59
|
| 271 |
+
ICB-BSR-0270,Crovalimab,ICH5457,C5,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,8.32
|
| 272 |
+
ICB-BSR-0271,Cudarolimab,ICH5458,TNFRSF4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,7.68
|
| 273 |
+
ICB-BSR-0272,Dalotuzumab,ICH5463,IGF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,8.42
|
| 274 |
+
ICB-BSR-0273,Dectrekumab,ICH5470,IL13,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.3,8.07
|
| 275 |
+
ICB-BSR-0274,Demcizumab,ICH5472,DLL4,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.4,6.62
|
| 276 |
+
ICB-BSR-0275,Demupitamab,ICH5473,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.8,7.43
|
| 277 |
+
ICB-BSR-0276,Dezamizumab,ICH5478,APCS,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.9,7.89
|
| 278 |
+
ICB-BSR-0277,Diridavumab,ICH5481,influenza A virus hemagglutinin HA2 subunit from various strains,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,144.2,8.51
|
| 279 |
+
ICB-BSR-0278,Disitamab,ICH5482,ERBB2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.2,8.06
|
| 280 |
+
ICB-BSR-0279,Disitamab Vedotin,ICH5482V,ERBB2 / HER2 / CD340,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.2,8.06
|
| 281 |
+
ICB-BSR-0280,Docaravimab,ICH5484,ERA,"standard IgG (2H+2L, theoretical from sequence)",IgG2b - kappa,146.5,6.48
|
| 282 |
+
ICB-BSR-0281,Domagrozumab,ICH5485,MSTN,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,143.9,8.32
|
| 283 |
+
ICB-BSR-0282,Donanemab,ICH5487,APP,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.1,8.31
|
| 284 |
+
ICB-BSR-0283,Dovanvetmab,ICH5489,Felcat IL31,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.2,6.77
|
| 285 |
+
ICB-BSR-0284,Drozitumab,ICH5491,TNFRSF10B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda3,143.1,7.89
|
| 286 |
+
ICB-BSR-0285,Duligotuzumab,ICH5493,ERBB3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.8,6.66
|
| 287 |
+
ICB-BSR-0286,Dusigitumab,ICH5494,IGF2,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,144.3,7.87
|
| 288 |
+
ICB-BSR-0287,Elezanumab,ICH5512,RGMA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.5,8.2
|
| 289 |
+
ICB-BSR-0288,Elgemtumab,ICH5513,ERBB3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.2,8.21
|
| 290 |
+
ICB-BSR-0289,Elipovimab,ICH5514,HIV-1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,146.8,7.91
|
| 291 |
+
ICB-BSR-0290,Emactuzumab,ICH5518,CSF1R,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.5,8.2
|
| 292 |
+
ICB-BSR-0291,Enapotamab,ICH5522,AXL,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,143.9,8.07
|
| 293 |
+
ICB-BSR-0292,Enapotamab Vedotin,ICH5522V,AXL / UFO,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,143.9,8.07
|
| 294 |
+
ICB-BSR-0293,Enavatuzumab,ICH5523,TNFRSF12A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,7.68
|
| 295 |
+
ICB-BSR-0294,Encelimab,ICH5524,LAG3,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.6,6.69
|
| 296 |
+
ICB-BSR-0295,Enoticumab,ICH5526,DLL4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.3,7.9
|
| 297 |
+
ICB-BSR-0296,Ensituximab,ICH5527,MUC5AC,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,142.9,8.32
|
| 298 |
+
ICB-BSR-0297,Etaracizumab,ICH5534,ITGAV_ITGB3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.3,8.44
|
| 299 |
+
ICB-BSR-0298,Etigilimab,ICH5536,TIGIT,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.1,8.58
|
| 300 |
+
ICB-BSR-0299,Favezelimab,ICH5545,LAG3,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.0,6.02
|
| 301 |
+
ICB-BSR-0300,Felzartamab,ICH5547,CD38,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.8,7.89
|
| 302 |
+
ICB-BSR-0301,Fianlimab,ICH5548,LAG3,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.4,8.07
|
| 303 |
+
ICB-BSR-0302,Firivumab,ICH5551,influenza A virus hemagglutinin HA [Influenza A virus],"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,8.22
|
| 304 |
+
ICB-BSR-0303,Flanvotumab,ICH5553,TYRP1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.32
|
| 305 |
+
ICB-BSR-0304,Foravirumab,ICH5555,RABV,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.3,8.33
|
| 306 |
+
ICB-BSR-0305,Frovocimab,ICH5558,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.4,7.09
|
| 307 |
+
ICB-BSR-0306,Frunevetmab,ICH5559,Felcat NGF,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,148.0,6.33
|
| 308 |
+
ICB-BSR-0307,Futuximab,ICH5560,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.3,7.16
|
| 309 |
+
ICB-BSR-0308,Garadacimab,ICH5563,F12,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - lambda,145.7,8.33
|
| 310 |
+
ICB-BSR-0309,Garetosmab,ICH5564,INHBA,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.6,8.08
|
| 311 |
+
ICB-BSR-0310,Gatipotuzumab,ICH5566,MUC1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.6,7.9
|
| 312 |
+
ICB-BSR-0311,Gatralimab,ICH5567,CD52,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.0,8.32
|
| 313 |
+
ICB-BSR-0312,Gedivumab,ICH5569,influenza A virus hemagglutinin HA [Influenza A virus],"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.7,8.33
|
| 314 |
+
ICB-BSR-0313,Giloralimab,ICH5571,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,8.21
|
| 315 |
+
ICB-BSR-0314,Gilvetmab,ICH5572,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,148.0,6.58
|
| 316 |
+
ICB-BSR-0315,Gimsilumab,ICH5574,CSF2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.8,8.34
|
| 317 |
+
ICB-BSR-0316,Glembatumumab Vedotin,ICH5575V,GPNMB,"standard IgG (2H+2L, theoretical from sequence)",IgG2-Kappa,145.3,7.87
|
| 318 |
+
ICB-BSR-0317,Glenzocimab,ICH5576,GP6,Fab fragment (1 H-fragment + 1 L),Fab - G1 - kappa,48.3,8.57
|
| 319 |
+
ICB-BSR-0318,Gosuranemab,ICH5582,MAPT,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.7,7.4
|
| 320 |
+
ICB-BSR-0319,Ianalumab,ICH5587,TNFRSF13C,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.6,8.51
|
| 321 |
+
ICB-BSR-0320,Icrucumab,ICH5589,FLT1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.8,8.07
|
| 322 |
+
ICB-BSR-0321,Ifabotuzumab,ICH5591,EPHA3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,8.06
|
| 323 |
+
ICB-BSR-0322,Iladatuzumab,ICH5593,CD79B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,6.63
|
| 324 |
+
ICB-BSR-0323,Iladatuzumab Vedotin,ICH5593V,CD79b,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,6.63
|
| 325 |
+
ICB-BSR-0324,Imalumab,ICH5595,MIF,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.7,8.33
|
| 326 |
+
ICB-BSR-0325,Imaprelimab,ICH5596,MCAM,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.7,8.51
|
| 327 |
+
ICB-BSR-0326,Imgatuzumab,ICH5600,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.1,8.5
|
| 328 |
+
ICB-BSR-0327,Inclacumab,ICH5602,SELP,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.5,7.39
|
| 329 |
+
ICB-BSR-0328,Indusatumab Vedotin,ICH5604V,GUCY2C,"standard IgG (2H+2L, theoretical from sequence)",IgG1(E356D/M358L)-Kappa,145.2,8.59
|
| 330 |
+
ICB-BSR-0329,Intetumumab,ICH5608,ITGAV_ITGB3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.43
|
| 331 |
+
ICB-BSR-0330,Iscalimab,ICH5610,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.08
|
| 332 |
+
ICB-BSR-0331,Itolizumab,ICH5611,CD6,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,8.31
|
| 333 |
+
ICB-BSR-0332,Labetuzumab Govitecan,ICH5617G,CEACAM5 / CEA / CD66e,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.5,8.07
|
| 334 |
+
ICB-BSR-0333,Lacnotuzumab,ICH5618,CSF1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.0,6.89
|
| 335 |
+
ICB-BSR-0334,Lacutamab,ICH5619,KIR3DL2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.8,7.43
|
| 336 |
+
ICB-BSR-0335,Ladiratuzumab,ICH5620,SLC39A6,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.0,7.9
|
| 337 |
+
ICB-BSR-0336,Ladiratuzumab Vedotin,ICH5620V,LIV-1 / SLC39A6,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.0,7.9
|
| 338 |
+
ICB-BSR-0337,Lampalizumab,ICH5622,CFD,Fab fragment (1 H-fragment + 1 L),Fab - G1 - kappa,47.0,7.64
|
| 339 |
+
ICB-BSR-0338,Landogrozumab,ICH5624,MSTN,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,142.9,7.42
|
| 340 |
+
ICB-BSR-0339,Laprituximab,ICH5626,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.0,7.87
|
| 341 |
+
ICB-BSR-0340,Laprituximab Emtansine,ICH5626E,ERBB1 / EGFR / HER1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.0,7.87
|
| 342 |
+
ICB-BSR-0341,Larcaviximab,ICH5627,Zaire Ebola virus,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.0,7.89
|
| 343 |
+
ICB-BSR-0342,Lenvervimab,ICH5632,HBV,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.5,8.32
|
| 344 |
+
ICB-BSR-0343,Leronlimab,ICH5634,CCR5,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.7,7.12
|
| 345 |
+
ICB-BSR-0344,Lesofavumab,ICH5637,influenza B virus hemagglutinin [Influenza B virus],"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.1,7.4
|
| 346 |
+
ICB-BSR-0345,Levilimab,ICH5639,IL6R,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,8.07
|
| 347 |
+
ICB-BSR-0346,Lexatumumab,ICH5640,TNFRSF10B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.6,8.21
|
| 348 |
+
ICB-BSR-0347,Ligelizumab,ICH5644,IGHE,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.6,7.16
|
| 349 |
+
ICB-BSR-0348,Lilotomab,ICH5645,CD37,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,6.51
|
| 350 |
+
ICB-BSR-0349,Lodapolimab,ICH5651,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda,143.9,8.21
|
| 351 |
+
ICB-BSR-0350,Lodelcizumab,ICH5652,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.42
|
| 352 |
+
ICB-BSR-0351,Lokivetmab,ICH5653,IL31,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,147.5,6.11
|
| 353 |
+
ICB-BSR-0352,Losatuxizumab,ICH5657,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.9,8.32
|
| 354 |
+
ICB-BSR-0353,Lumretuzumab,ICH5660,ERBB3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.9,8.31
|
| 355 |
+
ICB-BSR-0354,Lupartumab,ICH5663,LYPD3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.3,7.9
|
| 356 |
+
ICB-BSR-0355,Maftivimab,ICH5666,Zaire Ebola virus,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.0,8.43
|
| 357 |
+
ICB-BSR-0356,Manelimab,ICH5667,PD-L1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.6,7.91
|
| 358 |
+
ICB-BSR-0357,Marstacimab,ICH5671,TFPI,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,142.6,7.68
|
| 359 |
+
ICB-BSR-0358,Mezagitamab,ICH5679,CD38,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda,144.7,7.9
|
| 360 |
+
ICB-BSR-0359,Milatuzumab,ICH5681,CD74,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.7,8.52
|
| 361 |
+
ICB-BSR-0360,Mirikizumab,ICH5683,IL23A,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.8,7.89
|
| 362 |
+
ICB-BSR-0361,Mirococept,ICH5684,"complement C3b, C4b [Homo sapiens]","standard IgG (2H+2L, theoretical from sequence)","Conjugate - CR1 (complement receptor type 1, C3b/C4b receptor, C3BR, Knops blood group, KN, CD35) 41-238_peptidyl-myristoylated",254.1,5.23
|
| 363 |
+
ICB-BSR-0362,Miromavimab,ICH5685,ERA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.0,6.51
|
| 364 |
+
ICB-BSR-0363,Mirzotamab,ICH5687,CD276,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.9,7.89
|
| 365 |
+
ICB-BSR-0364,Mitazalimab,ICH5689,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.5,8.33
|
| 366 |
+
ICB-BSR-0365,Modotuximab,ICH5691,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.5,7.43
|
| 367 |
+
ICB-BSR-0366,Murlentamab,ICH5694,AMHR2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,8.76
|
| 368 |
+
ICB-BSR-0367,Namilumab,ICH5697,CSF2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.8,8.51
|
| 369 |
+
ICB-BSR-0368,Naratuximab,ICH5698,CD37,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,143.4,8.51
|
| 370 |
+
ICB-BSR-0369,Narnatumab,ICH5699,MST1R,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.0,8.43
|
| 371 |
+
ICB-BSR-0370,Narsoplimab,ICH5700,MASP2,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - lambda2,143.1,8.21
|
| 372 |
+
ICB-BSR-0371,Navivumab,ICH5702,influenza A virus hemagglutinin HA [Influenza A virus],"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.7,8.59
|
| 373 |
+
ICB-BSR-0372,Netakimab,ICH5709,IL17A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.0,8.07
|
| 374 |
+
ICB-BSR-0373,Nimacimab,ICH5711,CNR1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.0,7.9
|
| 375 |
+
ICB-BSR-0374,Nirsevimab,ICH5712,RSV,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,6.06
|
| 376 |
+
ICB-BSR-0375,Nurulimab,ICH5717,CTLA4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.1,8.21
|
| 377 |
+
ICB-BSR-0376,Obexelimab,ICH5719,CD19,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.5,7.67
|
| 378 |
+
ICB-BSR-0377,Ocaratuzumab,ICH5721,MS4A1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,8.32
|
| 379 |
+
ICB-BSR-0378,Odesivimab,ICH5723,Zaire Ebola virus,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.2,7.89
|
| 380 |
+
ICB-BSR-0379,Olendalizumab,ICH5727,C5,"standard IgG (2H+2L, theoretical from sequence)",IgG2-G4 - kappa,146.0,6.45
|
| 381 |
+
ICB-BSR-0380,Olinvacimab,ICH5729,KDR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - Vlambda-Ckappa,148.2,7.68
|
| 382 |
+
ICB-BSR-0381,Ongericimab,ICH5733,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.1,7.42
|
| 383 |
+
ICB-BSR-0382,Ontamalimab,ICH5734,MADCAM1,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,146.9,7.1
|
| 384 |
+
ICB-BSR-0383,Ontuxizumab,ICH5736,CD248,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.1,7.89
|
| 385 |
+
ICB-BSR-0384,Opicinumab,ICH5738,LINGO1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.5,7.11
|
| 386 |
+
ICB-BSR-0385,Orilanolimab,ICH5744,FCGRT,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.1,8.07
|
| 387 |
+
ICB-BSR-0386,Orticumab,ICH5746,oxLDL,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.7,8.6
|
| 388 |
+
ICB-BSR-0387,Osocimab,ICH5747,F11,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.2,6.84
|
| 389 |
+
ICB-BSR-0388,Otilimab,ICH5748,CSF2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,142.3,8.51
|
| 390 |
+
ICB-BSR-0389,Pacmilimab,ICH5752,PD-L1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,152.4,7.39
|
| 391 |
+
ICB-BSR-0390,Pamrevlumab,ICH5754,CTGF,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.2,8.06
|
| 392 |
+
ICB-BSR-0391,Pateclizumab,ICH5757,LTA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.7,8.42
|
| 393 |
+
ICB-BSR-0392,Pepinemab,ICH5768,SEMA4D,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.6,6.31
|
| 394 |
+
ICB-BSR-0393,Perakizumab,ICH5769,IL17A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,7.89
|
| 395 |
+
ICB-BSR-0394,Pidilizumab,ICH5773,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,8.31
|
| 396 |
+
ICB-BSR-0395,Plozalizumab,ICH5778,CCR2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.42
|
| 397 |
+
ICB-BSR-0396,Porgaviximab,ICH5780,Zaire Ebola virus,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.3,8.21
|
| 398 |
+
ICB-BSR-0397,Praluzatamab,ICH5785,ALCAM,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,156.3,7.17
|
| 399 |
+
ICB-BSR-0398,Praluzatamab Ravtansine,ICH5785R,ALCAM / CD166,"standard IgG (2H+2L, theoretical from sequence)",IgG1,156.3,7.17
|
| 400 |
+
ICB-BSR-0399,Prasinezumab,ICH5786,SNCA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,8.5
|
| 401 |
+
ICB-BSR-0400,Pritoxaximab,ICH5789,shiga toxin type 1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.5,7.17
|
| 402 |
+
ICB-BSR-0401,Prolgolimab,ICH5791,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - Vlambda-Ckappa,146.3,8.43
|
| 403 |
+
ICB-BSR-0402,Quavonlimab,ICH5794,CTLA4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.3,8.42
|
| 404 |
+
ICB-BSR-0403,Quetmolimab,ICH5795,CX3CL1,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,144.7,7.65
|
| 405 |
+
ICB-BSR-0404,Quilizumab,ICH5796,IGHE,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,7.9
|
| 406 |
+
ICB-BSR-0405,Racotumomab,ICH5797,idiotope of anti-,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.2,6.35
|
| 407 |
+
ICB-BSR-0406,Rafivirumab,ICH5799,RABV,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,145.8,7.88
|
| 408 |
+
ICB-BSR-0407,Ralpancizumab,ICH5801,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.3,8.39
|
| 409 |
+
ICB-BSR-0408,Ranevetmab,ICH5805,NGF,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.1,5.79
|
| 410 |
+
ICB-BSR-0409,Ravagalimab,ICH5806,CD40,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.0,8.2
|
| 411 |
+
ICB-BSR-0410,Refanezumab,ICH5810,MAG,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,148.3,7.41
|
| 412 |
+
ICB-BSR-0411,Relfovetmab,ICH5814,Felcat NGF,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,148.0,7.22
|
| 413 |
+
ICB-BSR-0412,Revdofilimab,ICH5818,TNFRSF4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,6.87
|
| 414 |
+
ICB-BSR-0413,Rinucumab,ICH5825,PDGFRB,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.6,7.9
|
| 415 |
+
ICB-BSR-0414,Ripertamab,ICH5826,MS4A1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,8.57
|
| 416 |
+
ICB-BSR-0415,Rivabazumab,ICH5827,PcrV protein type III secretion system,Fab fragment (1 H-fragment + 1 L),Fab' - G1 - kappa,49.0,8.14
|
| 417 |
+
ICB-BSR-0416,Roledumab,ICH5830,RHD,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.5,8.59
|
| 418 |
+
ICB-BSR-0417,Rontalizumab,ICH5835,IFNA1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.2,8.07
|
| 419 |
+
ICB-BSR-0418,Rosmantuzumab,ICH5836,RSPO3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.9,7.4
|
| 420 |
+
ICB-BSR-0419,Samrotamab,ICH5846,LRRC15,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.0,8.06
|
| 421 |
+
ICB-BSR-0420,Sasanlimab,ICH5848,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.5,7.39
|
| 422 |
+
ICB-BSR-0421,Semorinemab,ICH5850,MAPT,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.3,6.81
|
| 423 |
+
ICB-BSR-0422,Serclutamab,ICH5853,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.9,8.31
|
| 424 |
+
ICB-BSR-0423,Seribantumab,ICH5854,ERBB3,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,143.2,8.17
|
| 425 |
+
ICB-BSR-0424,Serplulimab,ICH5855,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.7,7.89
|
| 426 |
+
ICB-BSR-0425,Setoxaximab,ICH5856,shiga toxin type 2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.7,8.04
|
| 427 |
+
ICB-BSR-0426,Setrusumab,ICH5857,SOST,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,143.5,6.69
|
| 428 |
+
ICB-BSR-0427,Sirtratumab,ICH5868,SLITRK6,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,146.0,7.67
|
| 429 |
+
ICB-BSR-0428,Sirtratumab Vedotin,ICH5868V,SLITRK6,"standard IgG (2H+2L, theoretical from sequence)",IgG1,146.0,7.67
|
| 430 |
+
ICB-BSR-0429,Sirukumab,ICH5869,IL6,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,7.67
|
| 431 |
+
ICB-BSR-0430,Solanezumab,ICH5871,APP,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.4,8.33
|
| 432 |
+
ICB-BSR-0431,Spartalizumab,ICH5881,PDCD1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.8,6.59
|
| 433 |
+
ICB-BSR-0432,Spesolimab,ICH5882,IL1RL2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.9,8.43
|
| 434 |
+
ICB-BSR-0433,Suptavumab,ICH5887,RSV,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.07
|
| 435 |
+
ICB-BSR-0434,Suvizumab,ICH5890,HIV-1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,7.39
|
| 436 |
+
ICB-BSR-0435,Suvratoxumab,ICH5891,alpha toxin,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.6,8.07
|
| 437 |
+
ICB-BSR-0436,Tabituximab,ICH5892,FZD10,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.7,8.07
|
| 438 |
+
ICB-BSR-0437,Tadocizumab,ICH5893,ITGA2B_ITGB3,Fab fragment (1 H-fragment + 1 L),Fab - G1 - kappa,47.6,8.5
|
| 439 |
+
ICB-BSR-0438,Tafolecimab,ICH5894,PCSK9,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,145.1,8.05
|
| 440 |
+
ICB-BSR-0439,Talacotuzumab,ICH5896,IL3RA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.6,7.67
|
| 441 |
+
ICB-BSR-0440,Tamrintamab,ICH5898,DPEP3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.5,7.43
|
| 442 |
+
ICB-BSR-0441,Tamtuvetmab,ICH5899,CD52,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - Vkappa-Clambda,146.4,8.35
|
| 443 |
+
ICB-BSR-0442,Tarextumab,ICH5902,NOTCH2,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,143.2,8.05
|
| 444 |
+
ICB-BSR-0443,Tavolimab,ICH5903,TNFRSF4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,8.4
|
| 445 |
+
ICB-BSR-0444,Telazorlimab,ICH5909,TNFRSF4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,8.07
|
| 446 |
+
ICB-BSR-0445,Temelimab,ICH5912,endogenous retrovirus,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.3,7.89
|
| 447 |
+
ICB-BSR-0446,Tenatumomab,ICH5914,TNC,"standard IgG (2H+2L, theoretical from sequence)",IgG2b - kappa,147.9,7.41
|
| 448 |
+
ICB-BSR-0447,Tesidolumab,ICH5918,C5,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,142.9,6.84
|
| 449 |
+
ICB-BSR-0448,Tesnatilimab,ICH5919,KLRK1,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.9,6.63
|
| 450 |
+
ICB-BSR-0449,Tifcemalimab,ICH5920,BTLA,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.0,7.41
|
| 451 |
+
ICB-BSR-0450,Tigatuzumab,ICH5921,TNFRSF10B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.7,8.42
|
| 452 |
+
ICB-BSR-0451,Tilogotamab,ICH5922,TNFRSF10B,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,8.42
|
| 453 |
+
ICB-BSR-0452,Timigutuzumab,ICH5925,ERBB2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,8.32
|
| 454 |
+
ICB-BSR-0453,Timolumab,ICH5926,AOC3,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.5,7.39
|
| 455 |
+
ICB-BSR-0454,Tomaralimab,ICH5932,TLR2,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.4,6.56
|
| 456 |
+
ICB-BSR-0455,Tomuzotuximab,ICH5933,EGFR,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,7.9
|
| 457 |
+
ICB-BSR-0456,Tosatoxumab,ICH5936,alpha toxin,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda,145.0,8.51
|
| 458 |
+
ICB-BSR-0457,Tregalizumab,ICH5942,CD4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,147.5,7.66
|
| 459 |
+
ICB-BSR-0458,Trevogrumab,ICH5943,MSTN,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.1,7.06
|
| 460 |
+
ICB-BSR-0459,Ulocuplumab,ICH5954,CXCR4,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,146.3,7.37
|
| 461 |
+
ICB-BSR-0460,Urabrelimab,ICH5961,CD47,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,145.2,7.09
|
| 462 |
+
ICB-BSR-0461,Vadastuximab,ICH5964,CD33,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.9,7.65
|
| 463 |
+
ICB-BSR-0462,Vantictumab,ICH5967,frizzled family receptor,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - lambda,142.5,6.66
|
| 464 |
+
ICB-BSR-0463,Varisacumab,ICH5969,VEGFA,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.7,7.89
|
| 465 |
+
ICB-BSR-0464,Vatelizumab,ICH5970,ITGA2,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,144.6,7.1
|
| 466 |
+
ICB-BSR-0465,Vesencumab,ICH5977,NRP1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,8.42
|
| 467 |
+
ICB-BSR-0466,Vofatamab,ICH5986,FGFR3,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,7.67
|
| 468 |
+
ICB-BSR-0467,Volagidemab,ICH5987,GCGR,"standard IgG (2H+2L, theoretical from sequence)",IgG2 - kappa,147.0,8.04
|
| 469 |
+
ICB-BSR-0468,Vonlerolizumab,ICH5989,TNFRSF4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.3,8.2
|
| 470 |
+
ICB-BSR-0469,Vopratelimab,ICH5991,ICOS,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.8,7.44
|
| 471 |
+
ICB-BSR-0470,Vorsetuzumab,ICH5992,CD70,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.1,8.06
|
| 472 |
+
ICB-BSR-0471,Vorsetuzumab Mafodotin,ICH5992M,TNFSF7 / CD27L / CD70,"standard IgG (2H+2L, theoretical from sequence)",IgG1,146.1,8.06
|
| 473 |
+
ICB-BSR-0472,Vunakizumab,ICH5995,IL17A,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,146.4,7.41
|
| 474 |
+
ICB-BSR-0473,Xentuzumab,ICH5996,IGF2,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - lambda2,143.7,8.21
|
| 475 |
+
ICB-BSR-0474,Zalifrelimab,ICH5998,CTLA4,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,144.6,8.43
|
| 476 |
+
ICB-BSR-0475,Zampilimab,ICH6001,TGM2,"standard IgG (2H+2L, theoretical from sequence)",IgG4 - kappa,143.5,7.39
|
| 477 |
+
ICB-BSR-0476,Zanidatamab,ICH6002,ERBB2,bispecific / multi-chain (3 chains),half-IG G1 - kappa / (scFv - kappa - heavy) -h-CH2-CH3,124.8,7.92
|
| 478 |
+
ICB-BSR-0477,Zelminemab,ICH6005,ADCYAP1R1,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.2,8.5
|
| 479 |
+
ICB-BSR-0478,Ziltivekimab,ICH6008,IL6,"standard IgG (2H+2L, theoretical from sequence)",IgG1 - kappa,145.4,7.67
|
| 480 |
+
ICB-BSR-0479,Zenocutuzumab,ICH6013,,bispecific / multi-chain (4 chains),IgG1 - kappa,145.9,8.42
|
| 481 |
+
ICB-BSR-0480,Navicixizumab,ICH6020,VEGFA + DLL4,bispecific / multi-chain (4 chains),IgG2 - kappa,146.2,7.25
|